SEARCH
検索詳細
直 亨則 (ナオ ナガノリ)
| One Healthリサーチセンター 病因病態部門 | 特任准教授 |
| 人獣共通感染症国際共同研究所 | 特任准教授 |
研究活動情報
■ 論文- Characterization of inner capsid σA protein as a virulence factor of the pteropine orthoreovirus.
Hayato Harima; Michihito Sasaki; Takuma Ariizumi; Nijiho Kawaguchi; Hiroko Kobayashi; Kittiya Intaruck; Takeshi Kobayashi; Takahiro Kawagishi; Yuta Kanai; Naganori Nao; Yongjin Qiu; Masahiro Kajihara; Yasuko Orba; Naoto Ito; Kanako Ishihara; Masayuki Saijo; William W Hall; Bernard M Hang'ombe; Hirofumi Sawa
PLoS pathogens, 22, 5, e1014252, 2026年05月26日, [国際誌]
英語, 研究論文(学術雑誌), Pteropine orthoreovirus (PRV) is an emerging zoonotic virus that causes pneumonia in humans. We previously isolated the PRV strain Nachunsulwe-57 (N57) from a Zambian fruit bat and demonstrated its low virulence in laboratory mice. Here, we have attempted to identify factors responsible for differences in the virulence between strain N57 and the human-derived clinical strain Miyazaki-Bali/2007 (MB). Characterization of the virulence of recombinant monoreassortant PRVs derived from highly virulent MB and low virulent N57 strains in mice revealed that compared with wild-type (WT) MB, MB-based monoreassortants carrying the L1, S1, or S2 segment from N57 exhibited attenuated virulence. Among these, the monoreassortants carrying the S1 or S2 segment exhibited reduced viral loads and reduced cytokine gene expression levels in the lungs. Genetic mapping of virulence determinants using the reciprocal monoreassortant viruses with increased virulence demonstrated that N57-based monoreassortants carrying the S1 or S2 segment of MB exhibited enhanced virulence, resulting in lower survival rate compared with WT N57. Unlike the S1 segment, the functions of the S2 segment in pathogenesis are unclear. Thus, we further investigated the functional region of the inner-capsid σA protein encoded by the S2 segment. Notably, Ser-46 of σA was identified as a key amino acid determinant of PRV virulence and is present in strains derived from humans, monkeys, and bat flies, but not those identified from bats (their natural host). Collectively, these findings demonstrate that PRV σA is one factor that regulates virulence, and that σA Ser-46 may be related to potential interspecies transmission events from bats. - Analysis of HBV Genome Integration in Patients With HBV-Previously Infected NBNC-HCC.
Tomoya Saito; Rigel Suzuki; Akhinur Rahman; Kento Mori; Samiul Alam Rajib; Nobuhiro Kobayashi; Yoichi Yamamoto; Sharmin Nahar Sithi; Takaya Ichikawa; Tatsuya Orimo; Tatsuhiko Kakisaka; Lihan Liang; Naganori Nao; Saori Suzuki; Tomokazu Tamura; Yorifumi Satou; Akinobu Taketomi; Takasuke Fukuhara
Hepatology research : the official journal of the Japan Society of Hepatology, 2026年03月24日, [国際誌]
英語, 研究論文(学術雑誌), AIM: The incidence of non-B non-C hepatocellular carcinoma (NBNC-HCC), which is negative for Hepatitis B surface antigen and Hepatitis C virus antibodies, is on the rise. Relatively higher numbers of NBNC-HCC patients are Hepatitis B core antibody (HBcAb) positive, suggesting that previous HBV infection may play a role in NBNC-HCC development, though the exact mechanisms are unclear. This study aimed to investigate whether HBV genomes are integrated into the host genome of HBcAb-positive NBNC-HCC cases and how these integrations may contribute to cancer development and progression. METHODS: HBV detection PCR using HBV-specific primers on DNA extracted from HBcAb-positive NBNC-HCC tissue samples was performed. Positive samples were further examined for HBV integration sites using Viral DNA-Capture sequencing Approach. Additionally, Hepatitis B core-related antigen (HBcrAg) serum levels were measured to assess whether they could be predictive for HBV detection PCR results. RESULTS: Among 90 HBcAb-positive NBNC-HCC samples, HBV genome amplification was detected in 19 samples, and differences in HBcrAg status were observed according to HBV detection PCR results. Eighteen of these samples showed HBV integration. The HBV genome was integrated near the TERT gene in 7 samples, resulting in significantly increased TERT mRNA levels, in the KMT2B gene (3 samples), and downstream of the LOC441666 gene (2 samples). CONCLUSION: The integration sites we identified in our samples have been previously reported in HBV-related HCC, suggesting that HBV integration may also contribute to hepatocarcinogenesis in HBcAb-positive NBNC-HCC. Furthermore, HBcrAg could serve as a potential, noninvasive marker for detecting the HBV genome in these cases. - Tiled-Amplicon Whole-Genome Sequencing Method Reveals Endemic Circulation of Human Adenovirus Type 3 in Japan.
Gabriel Gonzalez; Naganori Nao; Koshiro Tabata; Yukari Itakura; Shinji Saito; Kenichiro Takahashi; Masaaki Kobayashi; Nobuyoshi Kitaichi; Nobuhisa Ishiguro; Tsuguto Fujimoto; Adriana E Kajon; Hirofumi Sawa; Nozomu Hanaoka
Viruses, 18, 1, 2026年01月05日, [国際誌]
英語, 研究論文(学術雑誌), Human adenovirus type 3 (HAdV-3) in the species Mastadenovirus blackbeardi is a frequent cause of hundreds of respiratory infections in Japan, with outbreaks varying in clinical severity. Such a high frequency of cases could be due to regular migration of novel variants or persistent circulation of endemic strains. Either scenario would require different measures to ameliorate the burden on public health. We designed a new cost-effective whole-genome sequencing protocol based on tiled amplicons and nanopore sequencing to clarify the circumstances behind the frequent outbreaks. This protocol was used with clinical samples collected between 2011 and 2020 from Japanese patients with acute respiratory illness (n = 110), resulting in near whole-genome sequences (~99% length) for 105 samples with high read coverage (~262.6 ± 192 reads). Phylogenetic analysis indicated sustained circulation of endemic strains in Japan during the analyzed decade and their relation to other strains worldwide with publicly available genome sequences. However, a comparison with other Japanese HAdV-3 strains circulating since 2023 suggested the public health measures introduced during the COVID-19 pandemic (2020-2022) indirectly affected the prevalence of circulating HAdV-3 variants. Additionally, our approach enabled the detection and partial sequencing (~71% completion) of co-infecting strains from the species Mastadenovirus caesari (n = 4) in the examined samples. The detection of adenoviruses belonging to different species in the same sample highlights how our protocol enhances the distinction of circulating viruses. In conclusion, these results and the introduced protocol will enable timely characterization and clinical interventions to mitigate this virus. - Presence or Emergence of Canine Leishmaniasis, Malawi
Boniface Chikufenji; Kyoko Hayashida; Yasuyuki Goto; Tatsuki Sugi; Chizu Sanjoba; Chrispin Njala; Inga McDermott; Frederic Lohr; Dagmar Mayer; Shohei Ogata; Masahiro Kajihara; Naganori Nao; Ryo Nakao; Laston Chimaliro; Donales Kapira; Janelisa Musaya; Junya Yamagishi; Elisha Chatanga
Emerging Infectious Diseases, 32, 1, Centers for Disease Control and Prevention (CDC), 2026年01月
研究論文(学術雑誌) - Genomic characterization of cefotaxime-resistant Proteobacteria isolated from a bat-harboring cave in Zambia.
Misheck Shawa; Harvey Kakoma Kamboyi; Herman Chambaro; Kyoko Hayashida; Naganori Nao; Joseph Chizimu; Mike Nundwe; Tuvshinzaya Zorigt; Naoko Kawai; Shohei Ogata; Joseph Ndebe; Mwamba Nsofwa; Msangwa Sinjani; Situmbeko J Nasilele; Mulemba Samutela; Manyando Simbotwe; Katendi Changula; Hirofumi Sawa; Bernard M Hang'ombe; Yasuhiko Suzuki; Masahiro Kajihara; Hideaki Higashi
New microbes and new infections, 68, 101661, 101661, 2025年12月, [国際誌]
英語, 研究論文(学術雑誌), Bats are widely recognized as reservoirs of emerging and re-emerging pathogens, and their ecological interactions with humans and livestock present important opportunities for the transmission of infectious agents and antimicrobial resistance (AMR). However, little is known about the occurrence of resistant bacteria in bat-associated environments in Zambia or their potential role in the maintenance of AMR outside clinical and agricultural settings. This study investigated the genomic characteristics of cefotaxime-resistant Proteobacteria isolated from bat fecal droppings collected at Leopards Hill Cave, an established hotspot for zoonotic pathogens. Four hundred bat fecal samples were cultured on cefotaxime-supplemented MacConkey agar, and those exhibiting bacterial growth were subjected to antimicrobial susceptibility testing and whole-genome analysis. Of the 400 samples processed, four (1 %) yielded growth, resulting in three bacterial species: Pseudomonas aeruginosa (n = 1), Enterobacter mori (n = 1), and Brucella intermedia (formerly Ochrobactrum intermedium) (n = 2). Genomic screening revealed that P. aeruginosa strain CB_234 harbored bla OXA-50, aph(3')-IIb, and catB7, which confer resistance to β-lactams, aminoglycosides, and chloramphenicol, respectively. It also possessed multiple virulence determinants involved in adherence, motility, and secretion systems that enhance host colonization and environmental persistence. Core genome phylogenetic analysis placed CB_234 within a clade exclusively composed of clinical isolates from Nigeria, Thailand, Russia, Kenya, and Ghana, indicating a shared evolutionary lineage among globally dispersed hospital-associated strains. Conversely, environmental isolates from plant and aquatic sources, along with a dog-associated isolate, were phylogenetically distant, highlighting the distinct evolutionary origins. The E. mori isolate carried bla ACT and qnrE resistance genes and plasmid replicons, suggesting potential mobility of resistance traits through horizontal gene transfer. In contrast, the two B. intermedia isolates did not harbor any known AMR genes or plasmid replicons. However, this species is increasingly recognized as an opportunistic pathogen. The detection of AMR-associated bacterial species in a natural bat habitat supports the evidence of resistance determinants circulating in wildlife environments in Zambia. Given that bats are unlikely to encounter clinical antibiotics directly, the persistence of such genes in their environment suggests that natural ecosystems may play an underappreciated role in maintaining AMR reservoirs independent of direct antimicrobial pressure. These findings underscore the importance of incorporating wildlife and environmental niches into national and global AMR surveillance frameworks under a One Health approach to better understand the ecological dimensions of AMR emergence and dissemination. - Oita virus rediscovered after 50 years: isolation of genetically conserved strains from bats in Southern Japan
Saiko Sawai; Kittiya Intaruck; Sho Sata; Mana Esaki; Kimitake Funakoshi; Shin Murakami; Keita Matsuno; Ryo Nakao; Kazunori Kimitsuki; Takaaki Yahiro; Akira Nishizono; Naganori Nao; Yasuko Orba; Ayato Takada; Masahiro Kajihara; Makoto Ozawa; Kosuke Okuya
Microbiology Spectrum, American Society for Microbiology, 2025年11月11日
研究論文(学術雑誌), ABSTRACT
Bats are natural reservoirs of numerous viruses, including members of the Rhabdoviridae family. Oita virus (OITV), classified within the genus Ledantevirus , was first isolated from the blood of a Japanese horseshoe bat ( Rhinolophus cornutus ) in the Oita Prefecture, Japan, in 1972. However, since then, no other OITV isolates have been reported. In this study, we isolated two OITV strains—OITV 321/2022 and OITV 326/2022—from oral swab samples of R. cornutus collected in the Katano Cave, Kagoshima Prefecture, Japan. Genetic analysis revealed >98% nucleotide identity with the previous isolate, OITV 296/1972. Phylogenetic analysis confirmed their classification within the Ledantevirus subgroup C. We assessed viral growth kinetics using 17 cell lines from diverse animal species, including bats, rodents, humans, and arthropods. OITV 321/2022 showed efficient replication in primate-derived, bat-derived, and human-derived cells, but not in tick or mosquito cell lines. Experimental infection of BALB/c mice demonstrated that OITV 321/2022 induced no overt clinical signs via either the intracerebral or intranasal routes. However, systemic infection and viral replication in the brain and lungs were observed by intracerebral inoculation. Intranasal inoculation with OITV 321/2022 and OITV 296/1972 resulted in transient pulmonary infection without systemic dissemination. This study provides evidence of OITV circulation in wild bat populations over 50 years, highlighting the need for continued surveillance of bat-associated rhabdoviruses in Japan.
IMPORTANCE
Bats are known reservoirs of zoonotic viruses, and their proximity to humans raises concerns regarding zoonotic risks. We report the first isolation of the Oita virus (OITV), a bat-associated ledantevirus, that has circulated for over 50 years. Unlike a previous blood-derived isolate, our isolates were obtained from oral swabs, suggesting their potential for respiratory transmission. OITV could infect a wide range of mammalian cells, including human-derived cells, and induce systemic infection in mice without clinical symptoms. These findings indicate that OITV possesses a broad host tropism and may circulate among microbats through the respiratory tract. Although the pathogenicity of the newly isolated strain appears to be attenuated compared with that of a historical brain-passaged strain, its ability to replicate in human cells underscores its potential zoonotic relevance, necessitating active surveillance and functional characterization of bat-derived rhabdoviruses to better assess emerging infectious disease threats. - Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases
Takaya Ichikawa; Tomokazu Tamura; Naganori Nao; Hikoyu Suzuki; Shuhei Maruyama; Daiki Wada; Shuhei Tsujino; Noriyoshi Yoshinaga; Kohsuke Asagoe; Mutsumi Takahata; Takashi Ishio; Makoto Ibata; Tanino Yoko; Yasutaka Kakinoki; Kazuhiro Okubo; Rigel Suzuki; Saori Suzuki; Yasushi Nakamori; Takanori Teshima; Takasuke Fukuhara
Antiviral Research, 242, 106264, 106264, Elsevier BV, 2025年10月
研究論文(学術雑誌) - In silico characterization of chromosomally integrated blaCTX-M genes among clinical Enterobacteriaceae in Africa: insights from whole-genome analysis
Misheck Shawa; Herman Chambaro; Harvey K. Kamboyi; Clement Sulwe; Joseph Y. Chizimu; Situmbeko J. Nasilele; Shohei Ogata; Mulemba Samutela; Tuvshinzaya Zorigt; Steward Mudenda; Manyando Simbotwe; Mwamba Nsofwa; Jedidiah Chanda; Freeman Chabala; Mike Nundwe; Joseph Ndebe; Msangwa Sinjani; Kyoko Hayashida; Naganori Nao; Roma Chilengi; Hirofumi Sawa; Yasuhiko Suzuki; Bernard Hang'ombe; Masahiro Kajihara; Hideaki Higashi
Frontiers in Microbiology, 16, Frontiers Media SA, 2025年09月12日
研究論文(学術雑誌), Antimicrobial resistance (AMR) mediated by extended-spectrum β-lactamases (ESBLs) is a growing global concern, particularly among Enterobacteriaceae. The CTX-M-type ESBLs, encoded by the blaCTX-M gene, are of significant public health importance due to their high prevalence and broad geographic distribution. Typically located on plasmids and often co-occurring with other AMR genes, blaCTX-M contributes to multidrug resistance (MDR). However, increasing evidence suggests secondary chromosomal integration of blaCTX-M, sometimes alongside other resistance determinants. The extent and implications of this mechanism remain poorly characterized, especially in Africa, where genomic surveillance is limited. In this study, we retrieved 295 chromosomal sequences of Enterobacteriaceae of African origin from the GenBank and performed in silico predictions of blaCTX-M and other AMR genes. blaCTX-M-carrying sequences were further characterized by in silico multilocus sequence typing and genome annotation. Chromosomal insertions were identified through alignment with reference genomes. Overall, 47 of 295 sequences (15.9%) harbored the blaCTX-M gene, with the highest prevalence in Klebsiella pneumoniae (29/157, 18.5%), followed by Escherichia coli (13/72, 18.1%), Enterobacter spp. (4/38, 10.5%), and Shigella spp. (1/12, 8.3%). The most common allele was blaCTX-M-15 (31/47, 66.0%), followed by blaCTX-M-14 (12/47, 25.5%), blaCTX-M-55 (3/47, 6.4%), and blaCTX-M-27 (1/27, 3.7%). Co-occurrence of blaCTX-M with additional AMR genes was frequently observed, with integration events often associated with mobile genetic elements such as ISEcp1 and IS26. Notably, strains from the same hospital setting were phylogenetically related and shared sequence types and AMR gene profiles, suggesting local clonal dissemination. These findings reveal a notable presence of chromosomally integrated blaCTX-M among African Enterobacteriaceae, frequently in association with other resistance genes, thereby facilitating stable MDR propagation independent of plasmid maintenance. This evolutionary adaptation may have significant implications for the persistence and spread of MDR in clinical settings. - 母子ともにリンパ腫を呈した牛におけるRAISING法を用いたクローナリティ解析
廣瀬 海鳳; 岡川 朋弘; 斎藤 益満; 松平 崇弘; 直 亨則; 前川 直也; 村田 史郎; 大橋 和彦; 今内 覚
日本獣医学会学術集会講演要旨集, 168回, 295, 295, (公社)日本獣医学会, 2025年09月
日本語 - A protein language model for exploring viral fitness landscapes
Jumpei Ito; Adam Strange; Wei Liu; Gustav Joas; Spyros Lytras; Keita Matsuno; Naganori Nao; Hirofumi Sawa; Keita Mizuma; Isshu Kojima; Jingshu Li; Tomoya Tsubo; Shinya Tanaka; Masumi Tsuda; Lei Wang; Yoshikata Oda; Zannatul Ferdous; Kenji Shishido; Takasuke Fukuhara; Tomokazu Tamura; Rigel Suzuki; Saori Suzuki; Shuhei Tsujino; Hayato Ito; Yu Kaku; Naoko Misawa; Arnon Plianchaisuk; Ziyi Guo; Alfredo A. Hinay; Kaoru Usui; Wilaiporn Saikruang; Keiya Uriu; Yusuke Kosugi; Shigeru Fujita; Jarel Elgin M.Tolentino; Luo Chen; Lin Pan; Wenye Li; Mai Suganami; Mika Chiba; Ryo Yoshimura; Kyoko Yasuda; Keiko Iida; Naomi Ohsumi; Shiho Tanaka; Kaho Okumura; Kazuhisa Yoshimura; Kenji Sadamas; Mami Nagashima; Hiroyuki Asakura; Isao Yoshida; So Nakagawa; Akifumi Takaori-Kondo; Kotaro Shirakawa; Kayoko Nagata; Ryosuke Nomura; Yoshihito Horisawa; Yusuke Tashiro; Yugo Kawai; Kazuo Takayama; Rina Hashimoto; Sayaka Deguchi; Yukio Watanabe; Yoshitaka Nakata; Hiroki Futatsusako; Ayaka Sakamoto; Naoko Yasuhara; Takao Hashiguchi; Tateki Suzuki; Kanako Kimura; Jiei Sasaki; Yukari Nakajima; Hisano Yajima; Takashi Irie; Ryoko Kawabata; Kaori Sasaki-Tabata; Terumasa Ikeda; Hesham Nasse; Ryo Shimizu; MST Monira Begum; Michael Jonathan; Yuka Mugita; Sharee Leong; Otowa Takahashi; Kimiko Ichihara; Takamasa Ueno; Chihiro Motozono; Mako Toyoda; Akatsuki Saito; Maya Shofa; Yuki Shibatani; Tomoko Nishiuchi; Jiri Zahradni; Prokopios Andrikopoulos; Miguel Padilla-Blanco; Aditi Konar; Kei Sato
Nature Communications, 16, 1, Springer Science and Business Media LLC, 2025年05月13日
研究論文(学術雑誌) - Development of a PCR-dipstick DNA chromatography-based tool for the detection of CTX-M- and TEM-producing Escherichia coli and Klebsiella pneumoniae isolated from patients in Kafue and Katete districts of Zambia.
Misheck Shawa; Kyoko Hayashida; Naganori Nao; Atmika Paudel; Harvey Kamboyi; Herman Chambaro; Malala Mulavu; Cynthia Sipho Khumalo; Mike Nundwe; Tuvshinzaya Zorigt; Chinatsu Nakamura; Yongjin Qiu; Naoko Kawai; Maisa Kasanga; Joseph Chizimu; Lavel Moonga; Joseph Ndebe; Manyando Simbotwe; Shohei Ogata; Mulemba Samutela; Chie Nakajima; Roma Chilengi; Mable Mutengo; Masahiro Kajihara; Hirofumi Sawa; Bernard Hang'ombe; Yasuhiko Suzuki; Hideaki Higashi
BMC infectious diseases, 25, 1, 541, 541, 2025年04月16日, [国際誌]
英語, 研究論文(学術雑誌), In Zambia, 40% of clinical Gram-negative bacteria are either Escherichia coli or Klebsiella pneumoniae, with a high third-generation cephalosporin (3GC) resistance prevalence. Therefore, 3GC resistance surveillance is a crucial indicator for guiding focused intervention policies. However, the lack of genotypic diagnostic tools limits the ability to elucidate trends, especially in peri-urban and rural areas of developing countries. This study aimed to develop a rapid, cost-effective tool for the genotypic surveillance of 3GC resistance. Here, 900 stool samples collected from patients in Kafue (peri-urban, n = 400) and Katete (rural, n = 500) districts of Zambia were used for bacterial isolation on MacConkey agar supplemented with 1 μg/ml cefotaxime. Isolated 3GC-resistant strains were characterized by sequencing the 16S rRNA gene and screening for blaCTX-M and blaTEM genes using single polymerase chain reaction (PCR). Furthermore, selected 3GC-resistant strains were subjected to whole-genome sequencing (WGS) using MiSeq/HiSeq (n = 34) and MinION (n = 1). Using the data from this and other previous studies, we developed a rapid PCR-dipstick DNA chromatography-based tool for detecting blaCTX-M, blaTEM, E. coli-specific yaiO, and K. pneumoniae-specific khe genes. The prevalence of isolated 3GC resistant strains was 15.4% (139/900), dominated by E. coli (102/139, 73.4%). On PCR, the blaCTX-M gene was detected in 72.7% (101/139) of the isolates, while blaTEM was found in 46.8% (65/139) of the strains. The developed tool displayed a high level of agreement with WGS and single PCR/Sanger sequencing, with sensitivity and specificity ≥ 95% and Kappa ≥ 0.95 for each of the four target genes. We envisage that the simplicity and adaptability of this tool will be a significant advantage for the surveillance of 3GC resistance in Zambia and elsewhere. - Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients
Chisako Iriyama; Takaya Ichikawa; Tomokazu Tamura; Mutsumi Takahata; Takashi Ishio; Makoto Ibata; Ryuji Kawai; Mitsunaga Iwata; Masahiro Suzuki; Hirokazu Adachi; Naganori Nao; Hikoyu Suzuki; Akito Kawai; Akifumi Kamiyama; Tadaki Suzuki; Yuichiro Hirata; Shun Iida; Harutaka Katano; Yasushi Ishii; Takahiro Tsuji; Yoshitaka Oda; Shinya Tanaka; Nanase Okazaki; Yuko Katayama; Shimpei Nakagawa; Tetsuya Tsukamoto; Yohei Doi; Takasuke Fukuhara; Takayuki Murata; Akihiro Tomita
PNAS Nexus, Oxford University Press (OUP), 2025年03月18日
研究論文(学術雑誌), Abstract
Patients with hematologic diseases have experienced COVID-19 with prolonged, progressive course. Here we present clinical, pathological, and virological analyses of three cases of prolonged COVID-19 among patients undergoing treatment for B-cell lymphoma. These patients had all been treated with anti-CD20 antibody and bendamustine. Despite various antiviral treatments, high SARS-CoV-2 levels persisted for more than 4 weeks, and two of them succumbed to COVID-19. Autopsy showed bronchopneumonia, interstitial pneumonia, alveolar hemorrhage, and fibrosis. Overlapping CMV, fungal and/or bacterial infections were also confirmed. Sequencing of SARS-CoV-2 showed accumulation of mutations and changes in variant allele frequencies over time. NSP12 mutations V792I and M794I appeared independently in two cases as COVID-19 progressed. In vitro drug susceptibility analysis and animal experiment using recombinant SARS-CoV-2 demonstrated that each mutation, V792 and M794I, was independently responsible for remdesivir resistance and attenuated pathogenicity. E340A, E340D and F342INS mutations in the spike protein were found in one case, which may account for the sotrovimab resistance. Analysis of autopsy specimens indicated heterogeneous distribution of these mutations. In summary, we demonstrated temporal and spatial diversity in SARS-CoV-2 that evolved resistance to various antiviral agents in malignant lymphoma patients under immunodeficient conditions caused by certain types of immunochemotherapies. Strategies may be necessary to prevent acquisition of drug resistance and improve outcome, such as selection of appropriate treatment strategies for lymphoma considering patients’ immune status and institution of early intensive antiviral therapy. - Evolution of BA.2.86 to JN.1 reveals functional changes in non-structural viral proteins are required for fitness of SARS-CoV-2
Shuhei Tsujino; Masumi Tsuda; Naganori Nao; Kaho Okumura; Lei Wang; Yoshitaka Oda; Yume Mimura; Jingshu Li; Rina Hashimoto; Yasufumi Matsumura; Rigel Suzuki; Saori Suzuki; Kumiko Yoshimatsu; Miki Nagao; Jumpei Ito; Kazuo Takayama; Kei Sato; Keita Matsuno; Tomokazu Tamura; Shinya Tanaka; Takasuke Fukuhara
Cold Spring Harbor Laboratory, 2025年02月19日
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19), is still circulating among humans, leading to the continuous evolution. SARS-CoV-2 Omicron JN.1 evolved from a distinct SARS-CoV-2 lineage, BA.2.86, spread rapidly worldwide. It is unclear why BA.2.86 did not become dominant and was quickly replaced by JN.1, which possesses one amino acid substitution in the spike protein (S:L455S) and two in the non-spike proteins NSP6 and ORF7b (NSP6:R252K and ORF7b:F19L) compared to BA.2.86. Here, we utilized recombinant viruses to elucidate the impact of these mutations on the virological characteristics of JN.1. We found that the mutation in the spike attenuated viral replication, but the non-spike mutations enhanced replication, suggesting the mutations in the non-spike proteins compensate for the one in the spike to improve viral fitness, as the mutations in the spike contribute to further immune evasion. Our findings suggest that functional changes in both the spike and non-spike proteins are necessary in the evolution of SARS-CoV-2 to enable evasion of adaptive immunity within the human population while sustaining replication.
IMPORTANCE
Because the spike protein is strongly associated with certain virological properties of SARS-CoV-2, such as immune evasion and infectivity, most previous studies on SARS-CoV-2 variants have focused on spike protein mutations. However, the non-spike proteins also contribute to infectivity, as observed throughout the evolution of Omicron subvariants. In this study, we demonstrate a “trade-off” strategy in SARS-CoV-2 Omicron JN.1 in which the reduced infectivity caused by spike mutation is compensated by non-spike mutations. Our results provide insight into the evolutionary scenario of the emerging virus in the human population. - Performance evaluation of an improved RAISING method for clonality analysis of bovine leukemia virus-infected cells: a collaborative study in Japan
Tomohiro OKAGAWA; Naomi NOJIRI; Hazuka YOSHIDA-FURIHATA; Naganori NAO; Misono TOMINAGA; Junko KOHARA; Satoshi GONDAIRA; Hidetoshi HIGUCHI; Yohei TAKEDA; Haruko OGAWA; Shinji YAMADA; Kenji MURAKAMI; Yasunori SUZUKI; Shinji TAKAI; Masaki MAEZAWA; Hisashi INOKUMA; Kaori SHIMIZU; Yasuo INOSHIMA; Tatsufumi USUI; Michihito TAGAWA; Mari YAMAMOTO; Hirohisa MEKATA; Mana ESAKI; Makoto OZAWA; Takahiro MATSUDAIRA; Naoya MAEKAWA; Shiro MURATA; Kazuhiko OHASHI; Masumichi SAITO; Satoru KONNAI
Journal of Veterinary Medical Science, Japanese Society of Veterinary Science, 2025年
研究論文(学術雑誌) - First identification and whole genome characterization of rotavirus C in pigs in Zambia.
Hayato Harima; Yongjin Qiu; Michihito Sasaki; Joseph Ndebe; Kapila Penjaninge; Edgar Simulundu; Masahiro Kajihara; Aiko Ohnuma; Keita Matsuno; Naganori Nao; Yasuko Orba; Ayato Takada; Kanako Ishihara; William W Hall; Bernard M Hang'ombe; Hirofumi Sawa
Virology, 603, 110385, 110385, 2024年12月31日, [国際誌]
英語, 研究論文(学術雑誌), Rotavirus C (RVC) causes acute gastroenteritis in neonatal piglets. Despite the clinical importance of RVC infection, the distribution and prevalence in pig populations in most African countries remains unknown. In this study, we identified RVC in Zambian pigs by metagenomic analysis. The full genome sequence of the RVC revealed two different VP4 sequences, implying that two different RVC strains (ZP18-77-c1 and ZP18-77-c2) were present in the same sample. Genetic analyses demonstrated that all segments of ZP18-77-c1 and ZP18-77-c2 showed high nucleotide sequence identities (87.7-94.5%) to known porcine RVC strains, and ZP18-77-c1 and ZP18-77-c2 strains were assigned to genotype constellations, G1-P[4]/P[14]-I13-R5-C5-M1-A7-N9-T10-E5-H1. We further screened RVC genomes among pig feces collected in Zambia (n = 147) by RT-qPCR, and 78 samples (53.1%) were positive. This study demonstrated the first full genome sequence of African RVC strains with a relatively high prevalence of RVC infection in the pig populations in Zambia. - A first report of rotavirus B from Zambian pigs leading to the discovery of a novel VP4 genotype P[9].
Hayato Harima; Yongjin Qiu; Michihito Sasaki; Joseph Ndebe; Kapila Penjaninge; Edgar Simulundu; Masahiro Kajihara; Aiko Ohnuma; Keita Matsuno; Naganori Nao; Yasuko Orba; Ayato Takada; Kanako Ishihara; William W Hall; Bernard M Hang'ombe; Hirofumi Sawa
Virology journal, 21, 1, 263, 263, 2024年10月24日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Rotavirus B (RVB) causes diarrhea in humans and pigs. Although various RVB strains were identified in humans and various animals globally, little is known about the epidemiology RVB infection in Africa. In this study, we attempted to examine the prevalence of RVB infection in pig populations in Zambia. METHODS: Metagenomic analyses were conducted on pig feces collected in Zambia to detect double stranded RNA viruses, including RVB. To clarify the prevalence of RVB infection in pig populations in Zambia, 147 fecal samples were screened for the RVB detection by RT-qPCR. Full genome sequence of a detected RVB was determined by Sanger sequencing and genetically analyzed. RESULTS: The metagenomic analyses revealed that RVB sequence reads and contigs of RVB were detected from one fecal sample collected from pigs in Zambia. RT-qPCR screening detected RVB genomes in 36.7% (54/147) of fecal samples. Among 54 positive samples, 13 were positive in non-diarrheal samples (n = 48, 27.1%) and 41 in diarrheal samples (n = 99, 41.4%). Genetic analyses demonstrated that all the segments of ZP18-18, except for VP4, had high nucleotide sequence identities (80.6-92.6%) with all other known RVB strains detected in pigs. In contrast, the VP4 sequence of ZP18-18 was highly divergent from other RVB strains (< 64.6% identities) and formed a distinct lineage in the phylogenetic tree. Notably, the VP8 subunit of the VP4 showed remarkably low amino acid identities (33.3%) to those of known RVB strains, indicating that the VP8 subunit of ZP18-18 was unique among RVB strains. According to the whole genome classification for RVB, ZP18-18 was assigned to a genotype constellation, G18-P[9]-I12-R4-C4-M4-A8-N10-T5-E4-H7 with the newly established VP4 genotype P[9]. CONCLUSIONS: This current study updates the geographical distribution and the genetic diversity of RVB. Given the lack of information regarding RVB in Africa, further RVB surveillance is required to assess the potential risk to humans and animals. - Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants
Hisano Yajima; Tomo Nomai; Kaho Okumura; Katsumi Maenaka; Jumpei Ito; Takao Hashiguchi; Kei Sato; Keita Matsuno; Naganori Nao; Hirofumi Sawa; Keita Mizuma; Jingshu Li; Izumi Kida; Yume Mimura; Yuma Ohari; Shinya Tanaka; Masumi Tsuda; Lei Wang; Yoshikata Oda; Zannatul Ferdous; Kenji Shishido; Hiromi Mohri; Miki Iida; Takasuke Fukuhara; Tomokazu Tamura; Rigel Suzuki; Saori Suzuki; Shuhei Tsujino; Hayato Ito; Yu Kaku; Naoko Misawa; Arnon Plianchaisuk; Ziyi Guo; Alfredo A. Hinay; Kaoru Usui; Wilaiporn Saikruang; Spyridon Lytras; Keiya Uriu; Ryo Yoshimura; Shusuke Kawakubo; Luca Nishumura; Yusuke Kosugi; Shigeru Fujita; Jarel Elgin M.Tolentino; Luo Chen; Lin Pan; Wenye Li; Maximilian Stanley Yo; Kio Horinaka; Mai Suganami; Mika Chiba; Kyoko Yasuda; Keiko Iida; Adam Patrick Strange; Naomi Ohsumi; Shiho Tanaka; Eiko Ogawa; Tsuki Fukuda; Rina Osujo; Kazuhisa Yoshimura; Kenji Sadamas; Mami Nagashima; Hiroyuki Asakura; Isao Yoshida; So Nakagawa; Kazuo Takayama; Rina Hashimoto; Sayaka Deguchi; Yukio Watanabe; Yoshitaka Nakata; Hiroki Futatsusako; Ayaka Sakamoto; Naoko Yasuhara; Tateki Suzuki; Kanako Kimura; Jiei Sasaki; Yukari Nakajima; Takashi Irie; Ryoko Kawabata; Kaori Sasaki-Tabata; Terumasa Ikeda; Hesham Nasser; Ryo Shimizu; Mst Monira Begum; Michael Jonathan; Yuka Mugita; Sharee Leong; Otowa Takahashi; Takamasa Ueno; Chihiro Motozono; Mako Toyoda; Akatsuki Saito; Anon Kosaka; Miki Kawano; Natsumi Matsubara; Tomoko Nishiuchi; Jiri Zahradnik; Prokopios Andrikopoulos; Miguel Padilla-Blanco; Aditi Konar
mBio, 15, 10, American Society for Microbiology, 2024年10月16日
研究論文(学術雑誌), ABSTRACT
Due to the incessant emergence of various SARS-CoV-2 variants with enhanced fitness in the human population, controlling the COVID-19 pandemic has been challenging. Understanding how the virus enhances its fitness during a pandemic could offer valuable insights for more effective control of viral epidemics. In this manuscript, we review the evolution of SARS-CoV-2 from early 2022 to the end of 2023—from Omicron BA.2 to XBB descendants. Focusing on viral evolution during this period, we provide concrete examples that SARS-CoV-2 has increased its fitness by enhancing several functions of the spike (S) protein, including its binding affinity to the ACE2 receptor and its ability to evade humoral immunity. Furthermore, we explore how specific mutations modify these functions of the S protein through structural alterations. This review provides evolutionary, molecular, and structural insights into how SARS-CoV-2 has increased its fitness and repeatedly caused epidemic surges during the pandemic. - Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1
Hisano Yajima; Yuki Anraku; Yu Kaku; Kanako Terakado Kimura; Arnon Plianchaisuk; Kaho Okumura; Yoshiko Nakada-Nakura; Yusuke Atarashi; Takuya Hemmi; Daisuke Kuroda; Yoshimasa Takahashi; Shunsuke Kita; Jiei Sasaki; Hiromi Sumita; Keita Matsuno; Naganori Nao; Hirofumi Sawa; Keita Mizuma; Jingshu Li; Izumi Kida; Yume Mimura; Yuma Ohari; Shinya Tanaka; Masumi Tsuda; Lei Wang; Yoshikata Oda; Zannatul Ferdous; Kenji Shishido; Hiromi Mohri; Miki Iida; Takasuke Fukuhara; Tomokazu Tamura; Rigel Suzuki; Saori Suzuki; Shuhei Tsujino; Hayato Ito; Naoko Misawa; Ziyi Guo; Alfredo A. Hinay; Kaoru Usui; Wilaiporn Saikruang; Spyridon Lytras; Keiya Uriu; Ryo Yoshimura; Shusuke Kawakubo; Luca Nishumura; Yusuke Kosugi; Shigeru Fujita; Jarel Elgin M.Tolentino; Luo Chen; Lin Pan; Wenye Li; Maximilian Stanley Yo; Kio Horinaka; Mai Suganami; Mika Chiba; Kyoko Yasuda; Keiko Iida; Adam Patrick Strange; Naomi Ohsumi; Shiho Tanaka; Eiko Ogawa; Tsuki Fukuda; Rina Osujo; Kazuhisa Yoshimura; Kenji Sadamas; Mami Nagashima; Hiroyuki Asakura; Isao Yoshida; So Nakagawa; Kazuo Takayama; Rina Hashimoto; Sayaka Deguchi; Yukio Watanabe; Yoshitaka Nakata; Hiroki Futatsusako; Ayaka Sakamoto; Naoko Yasuhara; Tateki Suzuki; Yukari Nakajima; Takashi Irie; Ryoko Kawabata; Kaori Sasaki-Tabata; Terumasa Ikeda; Hesham Nasser; Ryo Shimizu; M. S. T. Monira Begum; Michael Jonathan; Yuka Mugita; Sharee Leong; Otowa Takahashi; Takamasa Ueno; Chihiro Motozono; Mako Toyoda; Akatsuki Saito; Anon Kosaka; Miki Kawano; Natsumi Matsubara; Tomoko Nishiuchi; Jiri Zahradnik; Prokopios Andrikopoulos; Miguel Padilla-Blanco; Aditi Konar; Jumpei Ito; Katsumi Maenaka; Kei Sato; Takao Hashiguchi
Nature Communications, 15, 1, Springer Science and Business Media LLC, 2024年10月07日
研究論文(学術雑誌) - Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant.
Shuhei Tsujino; Sayaka Deguchi; Tomo Nomai; Miguel Padilla-Blanco; Arnon Plianchaisuk; Lei Wang; Mst Monira Begum; Keiya Uriu; Keita Mizuma; Naganori Nao; Isshu Kojima; Tomoya Tsubo; Jingshu Li; Yasufumi Matsumura; Miki Nagao; Yoshitaka Oda; Masumi Tsuda; Yuki Anraku; Shunsuke Kita; Hisano Yajima; Kaori Sasaki-Tabata; Ziyi Guo; Alfredo A Hinay Jr; Kumiko Yoshimatsu; Yuki Yamamoto; Tetsuharu Nagamoto; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Hesham Nasser; Michael Jonathan; Olivia Putri; Yoonjin Kim; Luo Chen; Rigel Suzuki; Tomokazu Tamura; Katsumi Maenaka; Takashi Irie; Keita Matsuno; Shinya Tanaka; Jumpei Ito; Terumasa Ikeda; Kazuo Takayama; Jiri Zahradnik; Takao Hashiguchi; Takasuke Fukuhara; Kei Sato
Microbiology and immunology, 2024年07月04日, [国際誌]
英語, 研究論文(学術雑誌), In middle to late 2023, a sublineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB, EG.5.1 (a progeny of XBB.1.9.2), is spreading rapidly around the world. We performed multiscale investigations, including phylogenetic analysis, epidemic dynamics modeling, infection experiments using pseudoviruses, clinical isolates, and recombinant viruses in cell cultures and experimental animals, and the use of human sera and antiviral compounds, to reveal the virological features of the newly emerging EG.5.1 variant. Our phylogenetic analysis and epidemic dynamics modeling suggested that two hallmark substitutions of EG.5.1, S:F456L and ORF9b:I5T are critical to its increased viral fitness. Experimental investigations on the growth kinetics, sensitivity to clinically available antivirals, fusogenicity, and pathogenicity of EG.5.1 suggested that the virological features of EG.5.1 are comparable to those of XBB.1.5. However, cryo-electron microscopy revealed structural differences between the spike proteins of EG.5.1 and XBB.1.5. We further assessed the impact of ORF9b:I5T on viral features, but it was almost negligible in our experimental setup. Our multiscale investigations provide knowledge for understanding the evolutionary traits of newly emerging pathogenic viruses, including EG.5.1, in the human population. - Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236.
Shigeru Fujita; Arnon Plianchaisuk; Sayaka Deguchi; Hayato Ito; Naganori Nao; Lei Wang; Hesham Nasser; Tomokazu Tamura; Izumi Kimura; Yukie Kashima; Rigel Suzuki; Saori Suzuki; Izumi Kida; Masumi Tsuda; Yoshitaka Oda; Rina Hashimoto; Yukio Watanabe; Keiya Uriu; Daichi Yamasoba; Ziyi Guo; Alfredo A Hinay Jr; Yusuke Kosugi; Luo Chen; Lin Pan; Yu Kaku; Hin Chu; Flora Donati; Sarah Temmam; Marc Eloit; Yuki Yamamoto; Tetsuharu Nagamoto; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Yutaka Suzuki; Jumpei Ito; Terumasa Ikeda; Shinya Tanaka; Keita Matsuno; Takasuke Fukuhara; Kazuo Takayama; Kei Sato
EBioMedicine, 104, 105181, 105181, 2024年06月, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Although several SARS-CoV-2-related coronaviruses (SC2r-CoVs) were discovered in bats and pangolins, the differences in virological characteristics between SARS-CoV-2 and SC2r-CoVs remain poorly understood. Recently, BANAL-20-236 (B236) was isolated from a rectal swab of Malayan horseshoe bat and was found to lack a furin cleavage site (FCS) in the spike (S) protein. The comparison of its virological characteristics with FCS-deleted SARS-CoV-2 (SC2ΔFCS) has not been conducted yet. METHODS: We prepared human induced pluripotent stem cell (iPSC)-derived airway and lung epithelial cells and colon organoids as human organ-relevant models. B236, SARS-CoV-2, and artificially generated SC2ΔFCS were used for viral experiments. To investigate the pathogenicity of B236 in vivo, we conducted intranasal infection experiments in hamsters. FINDINGS: In human iPSC-derived airway epithelial cells, the growth of B236 was significantly lower than that of the SC2ΔFCS. A fusion assay showed that the B236 and SC2ΔFCS S proteins were less fusogenic than the SARS-CoV-2 S protein. The infection experiment in hamsters showed that B236 was less pathogenic than SARS-CoV-2 and even SC2ΔFCS. Interestingly, in human colon organoids, the growth of B236 was significantly greater than that of SARS-CoV-2. INTERPRETATION: Compared to SARS-CoV-2, we demonstrated that B236 exhibited a tropism toward intestinal cells rather than respiratory cells. Our results are consistent with a previous report showing that B236 is enterotropic in macaques. Altogether, our report strengthens the assumption that SC2r-CoVs in horseshoe bats replicate primarily in the intestinal tissues rather than respiratory tissues. FUNDING: This study was supported in part by AMED ASPIRE (JP23jf0126002, to Keita Matsuno, Kazuo Takayama, and Kei Sato); AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers "UTOPIA" (JP223fa627001, to Kei Sato), AMED SCARDA Program on R&D of new generation vaccine including new modality application (JP223fa727002, to Kei Sato); AMED SCARDA Hokkaido University Institute for Vaccine Research and Development (HU-IVReD) (JP223fa627005h0001, to Takasuke Fukuhara, and Keita Matsuno); AMED Research Program on Emerging and Re-emerging Infectious Diseases (JP21fk0108574, to Hesham Nasser; JP21fk0108493, to Takasuke Fukuhara; JP22fk0108617 to Takasuke Fukuhara; JP22fk0108146, to Kei Sato; JP21fk0108494 to G2P-Japan Consortium, Keita Matsuno, Shinya Tanaka, Terumasa Ikeda, Takasuke Fukuhara, and Kei Sato; JP21fk0108425, to Kazuo Takayama and Kei Sato; JP21fk0108432, to Kazuo Takayama, Takasuke Fukuhara and Kei Sato; JP22fk0108534, Terumasa Ikeda, and Kei Sato; JP22fk0108511, to Yuki Yamamoto, Terumasa Ikeda, Keita Matsuno, Shinya Tanaka, Kazuo Takayama, Takasuke Fukuhara, and Kei Sato; JP22fk0108506, to Kazuo Takayama and Kei Sato); AMED Research Program on HIV/AIDS (JP22fk0410055, to Terumasa Ikeda; and JP22fk0410039, to Kei Sato); AMED Japan Program for Infectious Diseases Research and Infrastructure (JP22wm0125008 to Keita Matsuno); AMED CREST (JP21gm1610005, to Kazuo Takayama; JP22gm1610008, to Takasuke Fukuhara; JST PRESTO (JPMJPR22R1, to Jumpei Ito); JST CREST (JPMJCR20H4, to Kei Sato); JSPS KAKENHI Fund for the Promotion of Joint International Research (International Leading Research) (JP23K20041, to G2P-Japan Consortium, Keita Matsuno, Takasuke Fukuhara and Kei Sato); JST SPRING (JPMJSP2108 to Shigeru Fujita); JSPS KAKENHI Grant-in-Aid for Scientific Research C (22K07103, to Terumasa Ikeda); JSPS KAKENHI Grant-in-Aid for Scientific Research B (21H02736, to Takasuke Fukuhara); JSPS KAKENHI Grant-in-Aid for Early-Career Scientists (22K16375, to Hesham Nasser; 20K15767, to Jumpei Ito); JSPS Core-to-Core Program (A. Advanced Research Networks) (JPJSCCA20190008, to Kei Sato); JSPS Research Fellow DC2 (22J11578, to Keiya Uriu); JSPS Research Fellow DC1 (23KJ0710, to Yusuke Kosugi); JSPS Leading Initiative for Excellent Young Researchers (LEADER) (to Terumasa Ikeda); World-leading Innovative and Smart Education (WISE) Program 1801 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to Naganori Nao); Ministry of Health, Labour and Welfare (MHLW) under grant 23HA2010 (to Naganori Nao and Keita Matsuno); The Cooperative Research Program (Joint Usage/Research Center program) of Institute for Life and Medical Sciences, Kyoto University (to Kei Sato); International Joint Research Project of the Institute of Medical Science, the University of Tokyo (to Terumasa Ikeda and Takasuke Fukuhara); The Tokyo Biochemical Research Foundation (to Kei Sato); Takeda Science Foundation (to Terumasa Ikeda and Takasuke Fukuhara); Mochida Memorial Foundation for Medical and Pharmaceutical Research (to Terumasa Ikeda); The Naito Foundation (to Terumasa Ikeda); Hokuto Foundation for Bioscience (to Tomokazu Tamura); Hirose Foundation (to Tomokazu Tamura); and Mitsubishi Foundation (to Kei Sato). - Neutralizing immunity against coronaviruses in Tanzanian health care workers
Godfrey Barabona; Isaac Ngare; Doreen Kamori; Lilian Nkinda; Yusuke Kosugi; Ambele Mawazo; Rayi Ekwabi; Gloria Kinasa; Harrison Chuwa; Keita Matsuno; Naganori Nao; Hirofumi Sawa; Shinya Tanaka; Masumi Tsuda; Lei Wang; Yoshikata Oda; Zannatul Ferdous; Kenji Shishido; Takasuke Fukuhara; Tomokazu Tamura; Rigel Suzuki; Saori Suzuki; Hayato Ito; Yu Kaku; Naoko Misawa; Arnon Plianchaisuk; Ziyi Guo; Alfredo A. Hinay; Keiya Uriu; Jarel Elgin M. Tolentino; Luo Chen; Lin Pan; Mai Suganami; Mika Chiba; Ryo Yoshimura; Kyoko Yasuda; Keiko Iida; Naomi Ohsumi; Adam P. Strange; Shiho Tanaka; Kazuhisa Yoshimura; Kenji Sadamasu; Mami Nagashima; Hiroyuki Asakura; Isao Yoshida; So Nakagawa; Kotaro Shirakawa; Akifumi Takaori-Kondo; Kayoko Nagata; Ryosuke Nomura; Yoshihito Horisawa; Yusuke Tashiro; Yugo Kawai; Kazuo Takayama; Rina Hashimoto; Sayaka Deguchi; Yukio Watanabe; Ayaka Sakamoto; Naoko Yasuhara; Takao Hashiguchi; Tateki Suzuki; Kanako Kimura; Jiei Sasaki; Yukari Nakajima; Hisano Yajima; Takashi Irie; Ryoko Kawabata; Kaori Tabata; Terumasa Ikeda; Hesham Nasser; Ryo Shimizu; M. S. T. Monira Begum; Michael Jonathan; Yuka Mugita; Otowa Takahashi; Kimiko Ichihara; Chihiro Motozono; Takamasa Ueno; Mako Toyoda; Akatsuki Saito; Maya Shofa; Yuki Shibatani; Tomoko Nishiuchi; Kei Sato; Bruno Sunguya; Takamasa Ueno
Scientific Reports, 14, 1, Springer Science and Business Media LLC, 2024年03月06日
研究論文(学術雑誌), Abstract
The ongoing vaccination efforts and exposure to endemic and emerging coronaviruses can shape the population's immunity against this group of viruses. In this study, we investigated neutralizing immunity against endemic and emerging coronaviruses in 200 Tanzanian frontline healthcare workers (HCWs). Despite low vaccination rates (19.5%), we found a high SARS-CoV-2 seroprevalence (94.0%), indicating high exposure in these HCWs. Next, we determined the neutralization capacity of antisera against human coronavirus NL63, and 229E, SARS-CoV-1, MERS-CoV and SARS-CoV-2 (including Omicron subvariants: BA.1, BQ.1.1 and XBB.1.5) using pseudovirus neutralization assay. We observed a broad range of neutralizing activity in HCWs, but no neutralization activity detected against MERS-CoV. We also observed a strong correlation between neutralizing antibody titers for SARS-CoV-2 and SARS-CoV-1, but not between other coronaviruses. Cross-neutralization titers against the newer Omicron subvariants, BQ.1.1 and XBB.1.5, was significantly reduced compared to BA.1 and BA.2 subvariants. On the other hand, the exposed vaccinated HCWs showed relatively higher median cross-neutralization titers against both the newer Omicron subvariants and SARS-CoV-1, but did not reach statistical significance. In summary, our findings suggest a broad range of neutralizing potency against coronaviruses in Tanzanian HCWs with detectable neutralizing immunity against SARS-CoV-1 resulting from SARS-CoV-2 exposure. - Chimeric provirus of bovine leukemia virus/SMAD family member 3 in cattle with enzootic bovine leukosis.
Naganori Nao; Tomohiro Okagawa; Naomi Nojiri; Satoru Konnai; Honami Shimakura; Misono Tominaga; Hazuka Yoshida-Furihata; Eri Nishiyama; Takahiro Matsudaira; Naoya Maekawa; Shiro Murata; Masamichi Muramatsu; Kazuhiko Ohashi; Masumichi Saito
Archives of virology, 169, 3, 47, 47, 2024年02月16日, [国際誌]
英語, 研究論文(学術雑誌), Bovine leukemia virus (BLV) is a member of the family Retroviridae that causes enzootic bovine leukemia (EBL). However, the association between BLV infection and EBL development remains unclear. In this study, we identified a BLV/SMAD3 chimeric provirus within CC2D2A intron 30 in monoclonal expanded malignant cells from a cow with EBL. The chimeric provirus harbored a spliced SMAD3 sequence composed of exons 3-9, encoding the short isoform protein, and the BLV-SMAD3 chimeric transcript was detectable in cattle with EBL. This is the first report of a BLV chimeric provirus that might be involved in EBL tumorigenesis. - Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
Tomokazu Tamura; Keita Mizuma; Hesham Nasser; Sayaka Deguchi; Miguel Padilla-Blanco; Yoshitaka Oda; Keiya Uriu; Jarel E M Tolentino; Shuhei Tsujino; Rigel Suzuki; Isshu Kojima; Naganori Nao; Ryo Shimizu; Lei Wang; Masumi Tsuda; Michael Jonathan; Yusuke Kosugi; Ziyi Guo; Alfredo A Hinay Jr; Olivia Putri; Yoonjin Kim; Yuri L Tanaka; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Akatsuki Saito; Jumpei Ito; Takashi Irie; Shinya Tanaka; Jiri Zahradnik; Terumasa Ikeda; Kazuo Takayama; Keita Matsuno; Takasuke Fukuhara; Kei Sato
Cell host & microbe, 32, 2, 170, 180, 2024年02月14日, [国際誌]
英語, 研究論文(学術雑誌), In late 2023, several SARS-CoV-2 XBB descendants, notably EG.5.1, were predominant worldwide. However, a distinct SARS-CoV-2 lineage, the BA.2.86 variant, also emerged. BA.2.86 is phylogenetically distinct from other Omicron sublineages, accumulating over 30 amino acid mutations in its spike protein. Here, we examined the virological characteristics of the BA.2.86 variant. Our epidemic dynamics modeling suggested that the relative reproduction number of BA.2.86 is significantly higher than that of EG.5.1. Additionally, four clinically available antivirals were effective against BA.2.86. Although the fusogenicity of BA.2.86 spike is similar to that of the parental BA.2 spike, the intrinsic pathogenicity of BA.2.86 in hamsters was significantly lower than that of BA.2. Since the growth kinetics of BA.2.86 are significantly lower than those of BA.2 both in vitro and in vivo, the attenuated pathogenicity of BA.2.86 is likely due to its decreased replication capacity. These findings uncover the features of BA.2.86, providing insights for control and treatment. - Phylogenetic Analysis of Newcastle Disease Virus Isolated from Poultry in Live Bird Markets and Wild Waterfowl in Zambia.
Annie Kalonda; Ngonda Saasa; Masahiro Kajihara; Naganori Nao; Ladslav Moonga; Joseph Ndebe; Akina Mori-Kajihara; Andrew Nalishuwa Mukubesa; Yoshihiro Sakoda; Hirofumi Sawa; Ayato Takada; Edgar Simulundu
Microorganisms, 12, 2, 2024年02月08日, [国際誌]
英語, 研究論文(学術雑誌), Poultry production is essential to the economy and livelihood of many rural Zambian households. However, the industry is threatened by infectious diseases, particularly Newcastle disease virus (NDV) infection. Therefore, this study employed next-generation sequencing to characterise six NDV isolates from poultry in Zambia's live bird markets (LBMs) and wild waterfowl. Four NDV isolates were detected from 410 faecal samples collected from chickens in LBMs in Lusaka and two from 2851 wild birds from Lochinvar National Park. Phylogenetic analysis revealed that the four NDVs from LBM clustered in genotype VII and sub-genotype VII.2 were closely related to viruses previously isolated in Zambia and other Southern African countries, suggesting possible local and regional transboundary circulation of the virus. In contrast, the two isolates from wild birds belonged to class I viruses, genotype 1, and were closely related to isolates from Europe and Asia, suggesting the possible introduction of these viruses from Eurasia, likely through wild bird migration. The fusion gene cleavage site motif for all LBM-associated isolates was 112RRQKR|F117, indicating that the viruses are virulent, while the isolates from wild waterfowl had the typical 112ERQER|L117 avirulent motif. This study demonstrates the circulation of virulent NDV strains in LBMs and has, for the first time, characterised NDV from wild birds in Zambia. The study further provides the first whole genomes of NDV sub-genotype VII.2 and genotype 1 from Zambia and stresses the importance of surveillance and molecular analysis for monitoring the circulation of NDV genotypes and viral evolution. - No Evidence of SARS‐CoV‐2 Infection in Urban Wildlife of Hokkaido, Japan
Anastasiia Kovba; Naganori Nao; Michito Shimozuru; Mariko Sashika; Chihiro Takahata; Kei Sato; Keiya Uriu; Masami Yamanaka; Masanao Nakanishi; Genta Ito; Mebuki Ito; Miku Minamikawa; Kotaro Shimizu; Koichi Goka; Manabu Onuma; Keita Matsuno; Toshio Tsubota
Transboundary and Emerging Diseases, 2024, 1, Wiley, 2024年01月
研究論文(学術雑誌), Various domestic and wildlife species have been found susceptible to and infected with SARS‐CoV‐2, the causative agent of COVID‐19, around the globe, raising concerns about virus adaptation and transmission to new animal hosts. The virus circulation in the white‐tailed deer population in North America has further called to action for virus surveillance in the wildlife. Here, we report on the first SARS‐CoV‐2 survey of wild animals in Japan, where frequent wildlife invasions of urban areas have occurred due to the limited predation, field abandonment, the increase of human acclimatization. Genetic testing using nasal swabs and serological screening have been conducted for sika deer, brown bears, raccoons, and raccoon dogs captured in Hokkaido prefecture from the end of the Delta variant wave to the spread of the Omicron variant, between March 2022 and February 2023. No viral RNA was detected in raccoons (0/184), sika deer (0/107), and brown bears (0/14) indicating that the virus was unlikely to spread within the population of these animal species. Among 171 raccoons, 20 raccoon dogs, 100 sika deer, and 13 brown bears, one raccoon, one brown bear, and two deer tested positive in the antibodies screening with multispecies SARS‐CoV‐2 N‐protein ELISA. Still, ELISA‐positive samples tested negative in three other serological tests, emphasizing the importance of confirming serological screening results. Our results suggested that SARS‐CoV‐2 was unlikely to spillback from humans to wildlife in Hokkaido during the study period, with the emergence of new variants, continuous surveillance is of utmost importance. - Trends, patterns and relationship of antimicrobial use and resistance in bacterial isolates tested between 2015-2020 in a national referral hospital of Zambia.
Misheck Shawa; Atmika Paudel; Herman Chambaro; Harvey Kamboyi; Ruth Nakazwe; Luke Alutuli; Tuvshinzaya Zorigt; Taona Sinyawa; Mulemba Samutela; Joseph Chizimu; Manyando Simbotwe; Kyoko Hayashida; Naganori Nao; Masahiro Kajihara; Yoshikazu Furuta; Yasuhiko Suzuki; Hirofumi Sawa; Bernard Hang'ombe; Hideaki Higashi
PloS one, 19, 4, e0302053, 2024年, [国際誌]
英語, 研究論文(学術雑誌), Increased antimicrobial resistance (AMR) among bacteria underscores the need to strengthen AMR surveillance and promote data-based prescribing. To evaluate trends and associations between antimicrobial usage (AMU) and AMR, we explored a dataset of 34,672 bacterial isolates collected between 2015 and 2020 from clinical samples at the University Teaching Hospital (UTH) in Lusaka, Zambia. The most frequently isolated species were Escherichia coli (4,986/34,672; 14.4%), Staphylococcus aureus (3,941/34,672; 11.4%), and Klebsiella pneumoniae (3,796/34,672; 10.9%). Of the 16 drugs (eight classes) tested, only amikacin and imipenem showed good (> 50%) antimicrobial activity against both E. coli and K. pneumoniae, while nitrofurantoin was effective only in E. coli. Furthermore, 38.8% (1,934/4,980) of E. coli and 52.4% (2,079/3,791) of K. pneumoniae isolates displayed multidrug resistance (MDR) patterns on antimicrobial susceptibility tests. Among S. aureus isolates, 44.6% (973/2,181) were classified as methicillin-resistant (MRSA). Notably, all the MRSA exhibited MDR patterns. The annual hospital AMR rates varied over time, while there was a weak positive relationship (r = 0.38, 95% CI = 0.11-0.60) between the monthly use of third-generation cephalosporins (3GCs) and 3GC resistance among Enterobacterales. Overall, the results revealed high AMR rates that fluctuated over time, with a weak positive relationship between 3GC use and resistance. To our knowledge, this is the first report to evaluate the association between AMU and AMR in Zambia. Our results highlight the need to strengthen antimicrobial stewardship programs and optimize AMU in hospital settings. - Molecular epidemiology of human metapneumovirus before and after COVID-19 in East Japan in 2017-2022.
Kazuya Shirato; Reiko Suwa; Naganori Nao; Miyuki Kawase; Satoko Sugimoto; Yohei Kume; Mina Chishiki; Takashi Ono; Hisao Okabe; Sakurako Norito; Masatoki Sato; Hiroko Sakuma; Shigeo Suzuki; Mitsuaki Hosoya; Makoto Takeda; Koichi Hashimoto
Japanese journal of infectious diseases, 2023年12月28日, [国内誌]
英語, 研究論文(学術雑誌), Human metapneumovirus (hMPV) is genetically classified into two major subgroups, A and B, based on attachment glycoprotein (G) gene sequences, and the A2 subgroup is further separated into three subdivisions A2a, A2b (A2b1), and A2c (A2b2). The appearance of subgroup A2c viruses carrying a 180- or 111-nucleotide duplication in the G gene (A2c180nt-dup or A2c111nt-dup) have been reported in Japan and Spain. The pandemic of coronavirus disease 2019 (COVID-19) disrupted the epidemiological kinetics of other respiratory viruses, including hMPV. In this study, we analysed the sequences of hMPV isolates obtained from 2017 to 2022 in Tokyo and Fukushima, i.e., before and after COVID-19. Subgroup A hMPVs were detected in 2017 to 2019, and most cases were A2c111nt-dup, suggesting there was continuous momentum of this clade, identical to the global situation. Subgroup B, but not subgroup A, viruses were detected in 2022, after the COVID-19 peak. Phylogenetic analysis showed that these resumed subgroup B viruses were closely related to the viruses detected in 2013 to 2016 in Yokohama and in 2019 in Fukushima, suggesting a reappearance of local endemic viruses in East Japan. - A versatile method to profile hepatitis B virus DNA integration.
Kento Fukano; Kousho Wakae; Naganori Nao; Masumichi Saito; Akihito Tsubota; Takae Toyoshima; Hideki Aizaki; Hiroko Iijima; Takahiro Matsudaira; Moto Kimura; Koichi Watashi; Wataru Sugiura; Masamichi Muramatsu
Hepatology communications, 7, 12, 2023年12月01日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: HBV DNA integration into the host genome is frequently found in HBV-associated HCC tissues and is associated with hepatocarcinogenesis. Multiple detection methods, including hybrid capture-sequencing, have identified integration sites and provided clinical implications; however, each has advantages and disadvantages concerning sensitivity, cost, and throughput. Therefore, methods that can comprehensively and cost-effectively detect integration sites with high sensitivity are required. Here, we investigated the efficiency of RAISING (Rapid Amplification of Integration Site without Interference by Genomic DNA contamination) as a simple and inexpensive method to detect viral integration by amplifying HBV-integrated fragments using virus-specific primers covering the entire HBV genome. METHODS AND RESULTS: Illumina sequencing of RAISING products from HCC-derived cell lines (PLC/PRF/5 and Hep3B cells) identified HBV-human junction sequences as well as their frequencies. The HBV-human junction profiles identified using RAISING were consistent with those determined using hybrid capture-sequencing, and the representative junctions could be validated by junction-specific nested PCR. The comparison of these detection methods revealed that RAISING-sequencing outperforms hybrid capture-sequencing in concentrating junction sequences. RAISING-sequencing was also demonstrated to determine the sites of de novo integration in HBV-infected HepG2-NTCP cells, primary human hepatocytes, liver-humanized mice, and clinical specimens. Furthermore, we made use of xenograft mice subcutaneously engrafted with PLC/PRF/5 or Hep3B cells, and HBV-human junctions determined by RAISING-sequencing were detectable in the plasma cell-free DNA using droplet digital PCR. CONCLUSIONS: RAISING successfully profiles HBV-human junction sequences with smaller amounts of sequencing data and at a lower cost than hybrid capture-sequencing. This method is expected to aid basic HBV integration and clinical diagnosis research. - Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2
Shigeru Fujita; Yusuke Kosugi; Izumi Kimura; Kenzo Tokunaga; Jumpei Ito; Kei Sato; Keita Matsuno; Naganori Nao; Hirofumi Sawa; Shinya Tanaka; Masumi Tsuda; Lei Wang; Yoshikata Oda; Zannatul Ferdous; Kenji Shishido; Takasuke Fukuhara; Tomokazu Tamura; Rigel Suzuki; Saori Suzuki; Hayato Ito; Yu Kaku; Naoko Misawa; Arnon Plianchaisuk; Ziyi Guo; Alfredo A. Hinay; Keiya Uriu; Jarel Elgin M. Tolentino; Luo Chen; Lin Pan; Mai Suganami; Mika Chiba; Ryo Yoshimura; Kyoko Yasuda; Keiko Iida; Naomi Ohsumi; Adam P. Strange; Shiho Tanaka; Kazuhisa Yoshimura; Kenji Sadamasu; Mami Nagashima; Hiroyuki Asakura; Isao Yoshida; So Nakagawa; Akifumi Takaori-Kondo; Kayoko Nagata; Ryosuke Nomura; Yoshihito Horisawa; Yusuke Tashiro; Yugo Kawai; Kazuo Takayama; Rina Hashimoto; Sayaka Deguchi; Yukio Watanabe; Ayaka Sakamoto; Naoko Yasuhara; Takao Hashiguchi; Tateki Suzuki; Kanako Kimura; Jiei Sasaki; Yukari Nakajima; Hisano Yajima; Takashi Irie; Ryoko Kawabata; Kaori Tabata; Terumasa Ikeda; Hesham Nasser; Ryo Shimizu; M. S. T. Monira Begum; Michael Jonathan; Yuka Mugita; Otowa Takahashi; Kimiko Ichihara; Chihiro Motozono; Takamasa Ueno; Mako Toyoda; Akatsuki Saito; Maya Shofa; Yuki Shibatani; Tomoko Nishiuchi; Kotaro Shirakawa
Journal of Virology, 97, 10, 2023年10月31日
研究論文(学術雑誌) - Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
Tomokazu Tamura; Daichi Yamasoba; Yoshitaka Oda; Jumpei Ito; Tomoko Kamasaki; Naganori Nao; Rina Hashimoto; Yoichiro Fujioka; Rigel Suzuki; Lei Wang; Hayato Ito; Yukie Kashima; Izumi Kimura; Mai Kishimoto; Masumi Tsuda; Hirofumi Sawa; Kumiko Yoshimatsu; Yuki Yamamoto; Tetsuharu Nagamoto; Jun Kanamune; Yutaka Suzuki; Yusuke Ohba; Saori Suzuki; Marie Kato; Zannatul Ferdous; Hiromi Mouri; Kenji Shishido; Naoko Misawa; Keiya Uriu; Yusuke Kosugi; Shigeru Fujita; Mai Suganami; Mika Chiba; Ryo Yoshimura; So Nakagawa; Jiaqi Wu; Akifumi Takaori-Kondo; Kotaro Shirakawa; Kayoko Nagata; Yasuhiro Kazuma; Ryosuke Nomura; Yoshihito Horisawa; Yusuke Tashiro; Yugo Kawai; Takao Hashiguchi; Tateki Suzuki; Kanako Kimura; Jiei Sasaki; Yukari Nakajima; Ayaka Sakamoto; Naoko Yasuhara; Takashi Irie; Ryoko Kawabata; Terumasa Ikeda; Hesham Nasser; Ryo Shimizu; Monira Begum; Otowa Takahashi; Kimiko Ichihara; Takamasa Ueno; Chihiro Motozono; Mako Toyoda; Akatsuki Saito; Yuri L. Tanaka; Erika P. Butlertanaka; Maya Shofa; Kaori Tabata; Isao Yokota; Keita Matsuno; Kazuo Takayama; Shinya Tanaka; Kei Sato; Takasuke Fukuhara
Communications Biology, 6, 1, Springer Science and Business Media LLC, 2023年07月24日
研究論文(学術雑誌), Abstract
The unremitting emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants necessitates ongoing control measures. Given its rapid spread, the new Omicron subvariant BA.5 requires urgent characterization. Here, we comprehensively analyzed BA.5 with the other Omicron variants BA.1, BA.2, and ancestral B.1.1. Although in vitro growth kinetics of BA.5 was comparable among the Omicron subvariants, BA.5 was much more fusogenic than BA.1 and BA.2. Airway-on-a-chip analysis showed that, among Omicron subvariants, BA.5 had enhanced ability to disrupt the respiratory epithelial and endothelial barriers. Furthermore, in our hamster model, in vivo pathogenicity of BA.5 was slightly higher than that of the other Omicron variants and less than that of ancestral B.1.1. Notably, BA.5 gains efficient virus spread compared with BA.1 and BA.2, leading to prompt immune responses. Our findings suggest that BA.5 has low pathogenicity compared with the ancestral strain but enhanced virus spread /inflammation compared with earlier Omicron subvariants. - Impact of imprinted immunity induced by mRNA vaccination in an experimental animal model.
Shigeru Fujita; Keiya Uriu; Lin Pan; Naganori Nao; Koshiro Tabata; Mai Kishimoto; Yukari Itakura; Hirofumi Sawa; Izumi Kida; Tomokazu Tamura; Takasuke Fukuhara; Jumpei Ito; Keita Matsuno; Kei Sato
The Journal of infectious diseases, 2023年06月27日, [国際誌]
英語, 研究論文(学術雑誌), The emergence of SARS-CoV-2 Omicron variants has led to concerns that ancestral SARS-CoV-2-based vaccines may not be effective against newly emerging Omicron subvariants. The concept of "imprinted immunity" suggests that individuals vaccinated with ancestral virus-based vaccines may not develop effective immunity against newly emerging Omicron subvariants, such as BQ.1.1 and XBB.1. Here, we investigated this possibility using hamsters. While natural infection induced effective antiviral immunity, breakthrough infections in hamsters with BQ.1.1 and XBB.1 Omicron subvariants after receiving the 3-dose mRNA-LNP vaccine resulted in only faintly induced humoral immunity, supporting the possibility of imprinted immunity. - Surveillance, Isolation, and Genetic Characterization of Bat Herpesviruses in Zambia.
Hayato Harima; Yongjin Qiu; Junya Yamagishi; Masahiro Kajihara; Katendi Changula; Kosuke Okuya; Mao Isono; Tomoyuki Yamaguchi; Hirohito Ogawa; Naganori Nao; Michihito Sasaki; Edgar Simulundu; Aaron S Mweene; Hirofumi Sawa; Kanako Ishihara; Bernard M Hang'ombe; Ayato Takada
Viruses, 15, 6, 2023年06月13日, [国際誌]
英語, 研究論文(学術雑誌), Bats are of significant interest as reservoirs for various zoonotic viruses with high diversity. During the past two decades, many herpesviruses have been identified in various bats worldwide by genetic approaches, whereas there have been few reports on the isolation of infectious herpesviruses. Herein, we report the prevalence of herpesvirus infection of bats captured in Zambia and genetic characterization of novel gammaherpesviruses isolated from striped leaf-nosed bats (Macronycteris vittatus). By our PCR screening, herpesvirus DNA polymerase (DPOL) genes were detected in 29.2% (7/24) of Egyptian fruit bats (Rousettus aegyptiacus), 78.1% (82/105) of Macronycteris vittatus, and one Sundevall's roundleaf bat (Hipposideros caffer) in Zambia. Phylogenetic analyses of the detected partial DPOL genes revealed that the Zambian bat herpesviruses were divided into seven betaherpesvirus groups and five gammaherpesvirus groups. Two infectious strains of a novel gammaherpesvirus, tentatively named Macronycteris gammaherpesvirus 1 (MaGHV1), were successfully isolated from Macronycteris vittatus bats, and their complete genomes were sequenced. The genome of MaGHV1 encoded 79 open reading frames, and phylogenic analyses of the DNA polymerase and glycoprotein B demonstrated that MaGHV1 formed an independent lineage sharing a common origin with other bat-derived gammaherpesviruses. Our findings provide new information regarding the genetic diversity of herpesviruses maintained in African bats. - Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Tomokazu Tamura; Jumpei Ito; Keiya Uriu; Jiri Zahradnik; Izumi Kida; Yuki Anraku; Hesham Nasser; Maya Shofa; Yoshitaka Oda; Spyros Lytras; Naganori Nao; Yukari Itakura; Sayaka Deguchi; Rigel Suzuki; Lei Wang; Mst Monira Begum; Shunsuke Kita; Hisano Yajima; Jiei Sasaki; Kaori Sasaki-Tabata; Ryo Shimizu; Masumi Tsuda; Yusuke Kosugi; Shigeru Fujita; Lin Pan; Daniel Sauter; Kumiko Yoshimatsu; Saori Suzuki; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Yuki Yamamoto; Tetsuharu Nagamoto; Gideon Schreiber; Katsumi Maenaka; Takao Hashiguchi; Terumasa Ikeda; Takasuke Fukuhara; Akatsuki Saito; Shinya Tanaka; Keita Matsuno; Kazuo Takayama; Kei Sato
Nature communications, 14, 1, 2800, 2800, 2023年05月16日, [国際誌]
英語, 研究論文(学術雑誌), In late 2022, SARS-CoV-2 Omicron subvariants have become highly diversified, and XBB is spreading rapidly around the world. Our phylogenetic analyses suggested that XBB emerged through the recombination of two cocirculating BA.2 lineages, BJ.1 and BM.1.1.1 (a progeny of BA.2.75), during the summer of 2022. XBB.1 is the variant most profoundly resistant to BA.2/5 breakthrough infection sera to date and is more fusogenic than BA.2.75. The recombination breakpoint is located in the receptor-binding domain of spike, and each region of the recombinant spike confers immune evasion and increases fusogenicity. We further provide the structural basis for the interaction between XBB.1 spike and human ACE2. Finally, the intrinsic pathogenicity of XBB.1 in male hamsters is comparable to or even lower than that of BA.2.75. Our multiscale investigation provides evidence suggesting that XBB is the first observed SARS-CoV-2 variant to increase its fitness through recombination rather than substitutions. - Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant.
Jumpei Ito; Rigel Suzuki; Keiya Uriu; Yukari Itakura; Jiri Zahradnik; Kanako Terakado Kimura; Sayaka Deguchi; Lei Wang; Spyros Lytras; Tomokazu Tamura; Izumi Kida; Hesham Nasser; Maya Shofa; Mst Monira Begum; Masumi Tsuda; Yoshitaka Oda; Tateki Suzuki; Jiei Sasaki; Kaori Sasaki-Tabata; Shigeru Fujita; Kumiko Yoshimatsu; Hayato Ito; Naganori Nao; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Yuki Yamamoto; Tetsuharu Nagamoto; Jin Kuramochi; Gideon Schreiber; Akatsuki Saito; Keita Matsuno; Kazuo Takayama; Takao Hashiguchi; Shinya Tanaka; Takasuke Fukuhara; Terumasa Ikeda; Kei Sato
Nature communications, 14, 1, 2671, 2671, 2023年05月11日, [国際誌]
英語, 研究論文(学術雑誌), In late 2022, various Omicron subvariants emerged and cocirculated worldwide. These variants convergently acquired amino acid substitutions at critical residues in the spike protein, including residues R346, K444, L452, N460, and F486. Here, we characterize the convergent evolution of Omicron subvariants and the properties of one recent lineage of concern, BQ.1.1. Our phylogenetic analysis suggests that these five substitutions are recurrently acquired, particularly in younger Omicron lineages. Epidemic dynamics modelling suggests that the five substitutions increase viral fitness, and a large proportion of the fitness variation within Omicron lineages can be explained by these substitutions. Compared to BA.5, BQ.1.1 evades breakthrough BA.2 and BA.5 infection sera more efficiently, as demonstrated by neutralization assays. The pathogenicity of BQ.1.1 in hamsters is lower than that of BA.5. Our multiscale investigations illuminate the evolutionary rules governing the convergent evolution for known Omicron lineages as of 2022. - Surveillance and Phylogenetic Characterisation of Avian Influenza Viruses Isolated from Wild Waterfowl in Zambia in 2015, 2020, and 2021
Annie Kalonda; Ngonda Saasa; Masahiro Kajihara; Naganori Nao; Ladislav Moonga; Joseph Ndebe; Akina Mori-Kajihara; Andrew Nalishuwa Mukubesa; Mulemba Samutela; Samuel Munjita; Yoshihiro Sakoda; Hirofumi Sawa; Ayato Takada; Edgar Simulundu
Transboundary and Emerging Diseases, 2023, 1, 16, Hindawi Limited, 2023年03月01日
研究論文(学術雑誌), In recent years, the southern African region has experienced repeated incursions of highly pathogenic avian influenza viruses (HPAIVs), with wild migratory birds being implicated in the spread. To understand the profile of avian influenza viruses (AIVs) circulating in Zambia, we surveyed wild waterfowl for AIVs and phylogenetically characterised the isolates detected in 2015, 2020, and 2021. A total of 2,851 faecal samples of wild waterfowl were collected from Lochinvar National Park in the Southern Province of Zambia. During the study period, 85 (3.0%) low pathogenicity AIVs belonging to various subtypes were isolated, with H2N9, H8N4, and H10N8 being reported for the first time in avian species in Africa. The majority of the isolates were detected from glossy ibis (order Pelecaniformes) making it the first report of AIV from these birds in Zambia. Phylogenetic analysis of all eight gene segments of the 30 full genomes obtained in this study revealed that all the isolates belonged to the Eurasian lineage with their closest relatives being viruses isolated from wild and/or domestic birds in Bangladesh, Belgium, Egypt, Georgia, Mongolia, the Netherlands, and South Africa. Additionally, the Zambian viruses were grouped into distinct clusters based on the year of isolation. While no notifiable AIVs of the H5 or H7 subtypes were detected in wild birds in Zambia, viral internal protein genes of some viruses were closely related to H7 low pathogenicity AIVs. This study shows that periodically, a considerable diversity of AIV subtypes are introduced into the Zambian ecosystem by wild migratory waterfowl. The findings highlight the importance of continuous surveillance and monitoring of AIVs in wild waterfowl, including birds traditionally not considered to be major AIV reservoirs, for a better understanding of the eco-epidemiology and evolutionary dynamics of AIVs in Africa. - Field-deployable multiplex detection method of SARS-CoV-2 and influenza virus using loop-mediated isothermal amplification and DNA chromatography.
Kyoko Hayashida; Alejandro Garcia; Lavel Chinyama Moonga; Tatsuki Sugi; Kodera Takuya; Mitsuo Kawase; Fumihiro Kodama; Atsushi Nagasaka; Nobuhisa Ishiguro; Ayato Takada; Masahiro Kajihara; Naganori Nao; Masashi Shingai; Hiroshi Kida; Yasuhiko Suzuki; William W Hall; Hirofumi Sawa; Junya Yamagishi
PloS one, 18, 5, e0285861, 2023年, [国際誌]
英語, 研究論文(学術雑誌), A novel multiplex loop-mediated isothermal amplification (LAMP) method combined with DNA chromatography was developed for the simultaneous detection of three important respiratory disease-causing viruses: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus, and influenza B virus. Amplification was performed at a constant temperature, and a positive result was confirmed by a visible colored band. An in-house drying protocol with trehalose was used to prepare the dried format multiplex LAMP test. Using this dried multiplex LAMP test, the analytical sensitivity was determined to be 100 copies for each viral target and 100-1000 copies for the simultaneous detection of mixed targets. The multiplex LAMP system was validated using clinical COVID-19 specimens and compared with the real-time qRT-PCR method as a reference test. The determined sensitivity of the multiplex LAMP system for SARS-CoV-2 was 71% (95% CI: 0.62-0.79) for cycle threshold (Ct) ≤ 35 samples and 61% (95% CI: 0.53-0.69) for Ct ≤40 samples. The specificity was 99% (95%CI: 0.92-1.00) for Ct ≤35 samples and 100% (95%CI: 0.92-1.00) for the Ct ≤40 samples. The developed simple, rapid, low-cost, and laboratory-free multiplex LAMP system for the two major important respiratory viral diseases, COVID-19 and influenza, is a promising field-deployable diagnosis tool for the possible future 'twindemic, ' especially in resource-limited settings. - Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay
Hesham Nasser; Ryo Shimizu; Jumpei Ito; Akatsuki Saito; Kei Sato; Terumasa Ikeda; Keita Matsuno; Naganori Nao; Hirofumi Sawa; Mai Kishimoto; Shinya Tanaka; Masumi Tsuda; Lei Wang; Yoshikata Oda; Marie Kato; Zannatul Ferdous; Hiromi Mouri; Kenji Shishido; Takasuke Fukuhara; Tomokazu Tamura; Rigel Suzuki; Hayato Ito; Daichi Yamasoba; Izumi Kimura; Naoko Misawa; Keiya Uriu; Yusuke Kosugi; Shigeru Fujita; Mai Suganami; Mika Chiba; Ryo Yoshimura; So Nakagawa; Jiaqi Wu; Akifumi Takaori-Kondo; Kotaro Shirakawa; Kayoko Nagata; Yasuhiro Kazuma; Ryosuke Nomura; Yoshihito Horisawa; Yusuke Tashiro; Yugo Kawai; Takashi Irie; Ryoko Kawabata; MST Monira Begum; Otowa Takahashi; Kimiko Ichihara; Takamasa Ueno; Chihiro Motozono; Mako Toyoda; Yuri L. Tanaka; Erika P. Butlertanaka; Maya Shofa; Kazuo Takayama; Rina Hashimoto; Sayaka Deguchi; Takao Hashiguchi; Tateki Suzuki; Kanako Kimura; Jiei Sasaki; Yukari Nakajima; Kaori Tabata
STAR Protocols, 3, 4, 101773, 101773, Elsevier BV, 2022年12月
研究論文(学術雑誌) - Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.
Akatsuki Saito; Tomokazu Tamura; Jiri Zahradnik; Sayaka Deguchi; Koshiro Tabata; Yuki Anraku; Izumi Kimura; Jumpei Ito; Daichi Yamasoba; Hesham Nasser; Mako Toyoda; Kayoko Nagata; Keiya Uriu; Yusuke Kosugi; Shigeru Fujita; Maya Shofa; Mst Monira Begum; Ryo Shimizu; Yoshitaka Oda; Rigel Suzuki; Hayato Ito; Naganori Nao; Lei Wang; Masumi Tsuda; Kumiko Yoshimatsu; Jin Kuramochi; Shunsuke Kita; Kaori Sasaki-Tabata; Hideo Fukuhara; Katsumi Maenaka; Yuki Yamamoto; Tetsuharu Nagamoto; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Takamasa Ueno; Gideon Schreiber; Akifumi Takaori-Kondo; Kotaro Shirakawa; Hirofumi Sawa; Takashi Irie; Takao Hashiguchi; Kazuo Takayama; Keita Matsuno; Shinya Tanaka; Terumasa Ikeda; Takasuke Fukuhara; Kei Sato
Cell host & microbe, 30, 11, 1540, 1555, 2022年11月09日, [国際誌]
英語, 研究論文(学術雑誌), The SARS-CoV-2 Omicron BA.2.75 variant emerged in May 2022. BA.2.75 is a BA.2 descendant but is phylogenetically distinct from BA.5, the currently predominant BA.2 descendant. Here, we show that BA.2.75 has a greater effective reproduction number and different immunogenicity profile than BA.5. We determined the sensitivity of BA.2.75 to vaccinee and convalescent sera as well as a panel of clinically available antiviral drugs and antibodies. Antiviral drugs largely retained potency, but antibody sensitivity varied depending on several key BA.2.75-specific substitutions. The BA.2.75 spike exhibited a profoundly higher affinity for its human receptor, ACE2. Additionally, the fusogenicity, growth efficiency in human alveolar epithelial cells, and intrinsic pathogenicity in hamsters of BA.2.75 were greater than those of BA.2. Our multilevel investigations suggest that BA.2.75 acquired virological properties independent of BA.5, and the potential risk of BA.2.75 to global health is greater than that of BA.5. - Diagnosis and Early Prediction of Lymphoma Using High-Throughput Clonality Analysis of Bovine Leukemia Virus-Infected Cells.
Tomohiro Okagawa; Honami Shimakura; Satoru Konnai; Masumichi Saito; Takahiro Matsudaira; Naganori Nao; Shinji Yamada; Kenji Murakami; Naoya Maekawa; Shiro Murata; Kazuhiko Ohashi
Microbiology spectrum, 10, 6, e0259522, 2022年10月13日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Bovine leukemia virus (BLV), a retrovirus, infects B cells of ruminants and is integrated into the host genome as a provirus for lifelong infection. After a long latent period, 1% to 5% of BLV-infected cattle develop aggressive lymphoma, enzootic bovine leukosis (EBL). Since the clonal expansion of BLV-infected cells is essential for the development of EBL, the clonality of proviral integration sites could be a molecular marker for diagnosis and early prediction of EBL. Recently, we developed Rapid Amplification of the Integration Site without Interference by Genomic DNA Contamination (RAISING) and an analysis software of clonality value (CLOVA) to analyze the clonality of transgene-integrated cells. RAISING-CLOVA is capable of assessing the risk of adult T-cell leukemia/lymphoma development in human T-cell leukemia virus-I-infected individuals through the clonality analysis of proviral integration sites. Thus, we herein examined the performance of RAISING-CLOVA for the clonality analysis of BLV-infected cells and conducted a comprehensive clonality analysis by RAISING-CLOVA in EBL and non-EBL cattle. RAISING-CLOVA targeting BLV was a highly accurate and reproducible method for measuring the clonality value. The comprehensive clonality analysis successfully distinguished EBL from non-EBL specimens with high sensitivity and specificity. A longitudinal clonality analysis in BLV-infected sheep, an experimental model of lymphoma, also confirmed the effectiveness of RAISING-CLOVA for early detection of EBL development. Therefore, our study emphasizes the usefulness of RAISING-CLOVA as a routine clinical test for monitoring virus-related cancers. IMPORTANCE Bovine leukemia virus (BLV) infection causes aggressive B-cell lymphoma in cattle and sheep. The virus has spread to farms around the world, causing significant economic damage to the livestock industry. Thus, the identification of high-risk asymptomatic cattle before they develop lymphoma can be effective in reducing the economic damage. Clonal expansion of BLV-infected cells is a promising marker for the development of lymphoma. Recently, we have developed a high-throughput method to amplify random integration sites of transgenes in host genomes and analyze their clonality, named as RAISING-CLOVA. As a new application of our technology, in this study, we demonstrate the value of the RAISING-CLOVA method for the diagnosis and early prediction of lymphoma development by BLV infection in cattle. RAISING-CLOVA is a reliable technology for monitoring the clonality of BLV-infected cells and would contribute to reduce the economic losses by EBL development. - Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants including BA.4 and BA.5
Izumi Kimura; Daichi Yamasoba; Tomokazu Tamura; Naganori Nao; Tateki Suzuki; Yoshitaka Oda; Shuya Mitoma; Jumpei Ito; Hesham Nasser; Jiri Zahradnik; Keiya Uriu; Shigeru Fujita; Yusuke Kosugi; Lei Wang; Masumi Tsuda; Mai Kishimoto; Hayato Ito; Rigel Suzuki; Ryo Shimizu; M.S.T. Monira Begum; Kumiko Yoshimatsu; Kanako Terakado Kimura; Jiei Sasaki; Kaori Sasaki-Tabata; Yuki Yamamoto; Tetsuharu Nagamoto; Jun Kanamune; Kouji Kobiyama; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Kotaro Shirakawa; Akifumi Takaori-Kondo; Jin Kuramochi; Gideon Schreiber; Ken J. Ishii; Takao Hashiguchi; Terumasa Ikeda; Akatsuki Saito; Takasuke Fukuhara; Shinya Tanaka; Keita Matsuno; Kei Sato
Cell, Elsevier BV, 2022年09月
研究論文(学術雑誌) - ワンヘルスの実践と今後の可能性 動物・人・自然環境 北海道大学One Health Research Centerの紹介と最近の取組み
直 亨則; 松野 啓太; 山崎 淳平; 池中 良徳; 澤 洋文; 堀内 基広
日本獣医師会雑誌, 75, 7, 293, 297, (公社)日本獣医師会, 2022年07月
日本語 - RAISING is a high-performance method for identifying random transgene integration sites
Yusaku Wada; Tomoo Sato; Hiroo Hasegawa; Takahiro Matsudaira; Naganori Nao; Ariella L. G. Coler-Reilly; Tomohiko Tasaka; Shunsuke Yamauchi; Tomohiro Okagawa; Haruka Momose; Michikazu Tanio; Madoka Kuramitsu; Daisuke Sasaki; Nariyoshi Matsumoto; Naoko Yagishita; Junji Yamauchi; Natsumi Araya; Kenichiro Tanabe; Makoto Yamagishi; Makoto Nakashima; Shingo Nakahata; Hidekatsu Iha; Masao Ogata; Masamichi Muramatsu; Yoshitaka Imaizumi; Kaoru Uchimaru; Yasushi Miyazaki; Satoru Konnai; Katsunori Yanagihara; Kazuhiro Morishita; Toshiki Watanabe; Yoshihisa Yamano; Masumichi Saito
COMMUNICATIONS BIOLOGY, 5, 1, 2022年06月02日
英語, 研究論文(学術雑誌) - Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
Daichi Yamasoba; Izumi Kimura; Hesham Nasser; Yuhei Morioka; Naganori Nao; Jumpei Ito; Keiya Uriu; Masumi Tsuda; Jiri Zahradnik; Kotaro Shirakawa; Rigel Suzuki; Mai Kishimoto; Yusuke Kosugi; Kouji Kobiyama; Teppei Hara; Mako Toyoda; Yuri L Tanaka; Erika P Butlertanaka; Ryo Shimizu; Hayato Ito; Lei Wang; Yoshitaka Oda; Yasuko Orba; Michihito Sasaki; Kayoko Nagata; Kumiko Yoshimatsu; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Jin Kuramochi; Motoaki Seki; Ryoji Fujiki; Atsushi Kaneda; Tadanaga Shimada; Taka-Aki Nakada; Seiichiro Sakao; Takuji Suzuki; Takamasa Ueno; Akifumi Takaori-Kondo; Ken J Ishii; Gideon Schreiber; Hirofumi Sawa; Akatsuki Saito; Takashi Irie; Shinya Tanaka; Keita Matsuno; Takasuke Fukuhara; Terumasa Ikeda; Kei Sato
Cell, 185, 12, 2103, 2115, 2022年05月02日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Soon after the emergence and global spread of the SARS-CoV-2 Omicron lineage BA.1, another Omicron lineage, BA.2, began outcompeting BA.1. The results of statistical analysis showed that the effective reproduction number of BA.2 is 1.4-fold higher than that of BA.1. Neutralization experiments revealed that immunity induced by COVID vaccines widely administered to human populations is not effective against BA.2, similar to BA.1, and that the antigenicity of BA.2 is notably different from that of BA.1. Cell culture experiments showed that the BA.2 spike confers higher replication efficacy in human nasal epithelial cells and is more efficient in mediating syncytia formation than the BA.1 spike. Furthermore, infection experiments using hamsters indicated that the BA.2 spike-bearing virus is more pathogenic than the BA.1 spike-bearing virus. Altogether, the results of our multiscale investigations suggest that the risk of BA.2 to global health is potentially higher than that of BA.1. - Susceptibility of herons (family: Ardeidae) to clade 2.3.2.1 H5N1 subtype high pathogenicity avian influenza virus.
Kosuke Soda; Yukiko Tomioka; Tatsufumi Usui; Yukiko Uno; Yasuko Nagai; Hiroshi Ito; Takahiro Hiono; Tomokazu Tamura; Masatoshi Okamatsu; Masahiro Kajihara; Naganori Nao; Yoshihiro Sakoda; Ayato Takada; Toshihiro Ito
Avian pathology : journal of the W.V.P.A, 51, 2, 146, 153, 2022年04月, [国際誌]
英語, 研究論文(学術雑誌), The pathogenicity of the H5 subtype high pathogenicity avian influenza viruses (HPAIVs) in Ardeidae bird species has not been investigated yet, despite the increasing infections reported. Therefore, the present study aimed to examine the susceptibility of the Ardeidae species, which had already been reported to be susceptible to HPAIVs, to a clade 2.3.2.1 H5N1 HPAIV. Juvenile herons (four grey herons, one intermediate egret, two little egrets, and three black-crowned night herons) were intranasally inoculated with 106 50% egg infectious dose of the virus and observed for 10 days. Two of the four grey herons showed lethargy and conjunctivitis; among them, one died at 6 days post-inoculation (dpi). The viruses were transmitted to the other two cohoused naïve grey herons. Some little egrets and black-crowned night herons showing neurological disorders died at 4-5 dpi; these birds mainly shed the virus via the oral route. The viruses predominantly replicated in the brains of birds that died of infection. Seroconversion was observed in most surviving birds, except some black-crowned night herons. These results demonstrate that most Ardeidae species are susceptible to H5 HPAIVs, sometimes with lethal effects. Herons are mostly colonial and often share habitats with Anseriformes, natural hosts of influenza A viruses; therefore, the risks of cluster infection and contribution to viral dissemination should be continuously evaluated. RESEARCH HIGHLIGHTSClade 2.3.2.1 H5N1 HPAIV causes lethal infections in Ardeidae sp.Viruses are transmitted among grey herons.Some herons with HPAIV showed conjunctivitis or neurological symptoms.HPAIV systemically replicated in herons tissues. - Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
Rigel Suzuki; Daichi Yamasoba; Izumi Kimura; Lei Wang; Mai Kishimoto; Jumpei Ito; Yuhei Morioka; Naganori Nao; Hesham Nasser; Keiya Uriu; Yusuke Kosugi; Masumi Tsuda; Yasuko Orba; Michihito Sasaki; Ryo Shimizu; Ryoko Kawabata; Kumiko Yoshimatsu; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Hirofumi Sawa; Terumasa Ikeda; Takashi Irie; Keita Matsuno; Shinya Tanaka; Takasuke Fukuhara; Kei Sato
Nature, 603, 7902, 700, 705, 2022年03月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), The emergence of the Omicron variant of SARS-CoV-2 is an urgent global health concern1. In this study, our statistical modelling suggests that Omicron has spread more rapidly than the Delta variant in several countries including South Africa. Cell culture experiments showed Omicron to be less fusogenic than Delta and than an ancestral strain of SARS-CoV-2. Although the spike (S) protein of Delta is efficiently cleaved into two subunits, which facilitates cell-cell fusion2,3, the Omicron S protein was less efficiently cleaved compared to the S proteins of Delta and ancestral SARS-CoV-2. Furthermore, in a hamster model, Omicron showed decreased lung infectivity and was less pathogenic compared to Delta and ancestral SARS-CoV-2. Our multiscale investigations reveal the virological characteristics of Omicron, including rapid growth in the human population, lower fusogenicity and attenuated pathogenicity. - Structural Requirements in the Hemagglutinin Cleavage Site-Coding RNA Region for the Generation of Highly Pathogenic Avian Influenza Virus.
Yurie Kida; Kosuke Okuya; Takeshi Saito; Junya Yamagishi; Aiko Ohnuma; Takanari Hattori; Hiroko Miyamoto; Rashid Manzoor; Reiko Yoshida; Naganori Nao; Masahiro Kajihara; Tokiko Watanabe; Ayato Takada
Pathogens (Basel, Switzerland), 10, 12, 2021年12月09日, [国際誌]
英語, 研究論文(学術雑誌), Highly pathogenic avian influenza viruses (HPAIVs) with H5 and H7 hemagglutinin (HA) subtypes are derived from their low pathogenic counterparts following the acquisition of multiple basic amino acids in their HA cleavage site. It has been suggested that consecutive adenine residues and a stem-loop structure in the viral RNA region that encodes the cleavage site are essential for the acquisition of the polybasic cleavage site. By using a reporter assay to detect non-templated nucleotide insertions, we found that insertions more frequently occurred in the RNA region (29 nucleotide-length) encoding the cleavage site of an H5 HA gene that was predicted to have a stem-loop structure containing consecutive adenines than in a mutated corresponding RNA region that had a disrupted loop structure with fewer adenines. In virus particles generated by using reverse genetics, nucleotide insertions that created additional codons for basic amino acids were found in the RNA region encoding the cleavage site of an H5 HA gene but not in the mutated RNA region. We confirmed the presence of virus clones with the ability to replicate without trypsin in a plaque assay and to cause lethal infection in chicks. These results demonstrate that the stem-loop structure containing consecutive adenines in HA genes is a key molecular determinant for the emergence of H5 HPAIVs. - Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship.
Takuya Yamagishi; Makoto Ohnishi; Nobuaki Matsunaga; Kensaku Kakimoto; Hajime Kamiya; Kiyoko Okamoto; Motoi Suzuki; Yoshiaki Gu; Mikiyo Sakaguchi; Taichi Tajima; Saho Takaya; Norio Ohmagari; Makoto Takeda; Shutoku Matsuyama; Kazuya Shirato; Naganori Nao; Hideki Hasegawa; Tsutomu Kageyama; Ikuyo Takayama; Shinji Saito; Koji Wada; Retsu Fujita; Hiroki Saito; Keiji Okinaka; Mathew Griffith; Amy Elizabeth Parry; Brenda Barnetson; James Leonard; Takaji Wakita
The Journal of infectious diseases, 223, 3, 540, 540, 2021年02月13日, [国際誌]
英語, 研究論文(学術雑誌) - The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells.
Shutoku Matsuyama; Miyuki Kawase; Naganori Nao; Kazuya Shirato; Makoto Ujike; Wataru Kamitani; Masayuki Shimojima; Shuetsu Fukushi
Journal of virology, 95, 1, 2020年12月09日, [国際誌]
英語, 研究論文(学術雑誌), Here, we screened steroid compounds to obtain a drug expected to block host inflammatory responses and Middle East respiratory syndrome coronavirus (MERS-CoV) replication. Ciclesonide, an inhaled corticosteroid, suppressed the replication of MERS-CoV and other coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), in cultured cells. The 90% effective concentration (EC90) of ciclesonide for SARS-CoV-2 in differentiated human bronchial tracheal epithelial cells was 0.55 μM. Eight consecutive passages of 43 SARS-CoV-2 isolates in the presence of ciclesonide generated 15 resistant mutants harboring single amino acid substitutions in nonstructural protein 3 (nsp3) or nsp4. Of note, ciclesonide suppressed the replication of all these mutants by 90% or more, suggesting that these mutants cannot completely overcome ciclesonide blockade. Under a microscope, the viral RNA replication-transcription complex in cells, which is thought to be detectable using antibodies specific for nsp3 and double-stranded RNA, was observed to fall in the presence of ciclesonide in a concentration-dependent manner. These observations indicate that the suppressive effect of ciclesonide on viral replication is specific to coronaviruses, highlighting it as a candidate drug for the treatment of COVID-19 patients.IMPORTANCE The outbreak of SARS-CoV-2, the cause of COVID-19, is ongoing. New and effective antiviral agents that combat the disease are needed urgently. Here, we found that an inhaled corticosteroid, ciclesonide, suppresses the replication of coronaviruses, including betacoronaviruses (murine hepatitis virus type 2 [MHV-2], MERS-CoV, SARS-CoV, and SARS-CoV-2) and an alphacoronavirus (human coronavirus 229E [HCoV-229E]), in cultured cells. Ciclesonide is safe; indeed, it can be administered to infants at high concentrations. Thus, ciclesonide is expected to be a broad-spectrum antiviral drug that is effective against many members of the coronavirus family. It could be prescribed for the treatment of MERS and COVID-19. - Epidemiology of COVID-19 Outbreak on Cruise Ship Quarantined at Yokohama, Japan, February 2020
Hajime Kamiya; Hiroyuki Fujikura; Ikuko Doi; Kensaku Kakimoto; Motoi Suzuki; Tamano Matsui; Tomimasa Sunagawa; Takuri Takahashi; Takuya Yamagishi; Anita Samuel; Naganori Nao; Ikuyo Takayama; Shinji Saito; Hideki Asanuma; Tsutomu Kageyama; Kiyoko Okamoto; Makoto Ohnishi; Takaji Wakita; Natalie M. Linton; Keita Yoshii; Tetsuro Kobayashi; Abdi Rahman Mahamud; Matthew M. Griffith
EMERGING INFECTIOUS DISEASES, 26, 11, 2591, 2597, 2020年11月
英語, 研究論文(学術雑誌) - Assessment of Real-Time RT-PCR Kits for SARS-CoV-2 Detection.
Kiyoko Okamaoto; Kazuya Shirato; Naganori Nao; Shinji Saito; Tsutomu Kageyama; Hideki Hasegawa; Tadaki Suzuki; Shutoku Matsuyama; Makoto Takeda
Japanese journal of infectious diseases, 73, 5, 366, 368, 2020年09月24日, [国内誌]
英語, 研究論文(学術雑誌), The coronavirus induced disease 2019 (COVID-19) outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan (China) in December 2019 is currently spreading rapidly worldwide. We recently reported a laboratory protocol for the diagnosis of SARS-CoV-2 based on real-time reverse transcriptase PCR (RT-PCR) assays using two primer sets, N and N2. On January 30-31, 2020, the protocol and the reagents for these assays were distributed to the local public health institutes and quarantine depots in Japan nationwide, and thereafter SARS-CoV-2 diagnostic testing was initiated. For further validation, the assays were compared with the commercially available kits using the SARS-CoV-2 viral RNA and clinical specimens obtained from COVID19-suspected individuals. The LightMix Modular SARS and Wuhan CoV E-gene (LM S&W-E) assay was highly sensitive for the SARS-CoV-2, as was the N2 set, as both the assays showed consistent results for the clinical specimens. While the LM S&W-E set targets the highly conserved region of E gene in the SARS-CoV and SARS-CoV-2, the N2 set was designed to target specifically the unique region in the SARS-CoV-2 N gene. Therefore, the N2 set exhibits high specificity and sensitivity for SARS-CoV-2 detection. These results indicate that the protocol using the N and N2 sets is comparable to the commercially available kits, and thus is reliable for laboratory diagnosis of COVID-19. - A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo.
Masumichi Saito; Hiroo Hasegawa; Shunsuke Yamauchi; So Nakagawa; Daisuke Sasaki; Naganori Nao; Michikazu Tanio; Yusaku Wada; Takahiro Matsudaira; Haruka Momose; Madoka Kuramitsu; Makoto Yamagishi; Makoto Nakashima; Shingo Nakahata; Hidekatsu Iha; Masao Ogata; Yoshitaka Imaizumi; Kaoru Uchimaru; Kazuhiro Morishita; Toshiki Watanabe; Yasushi Miyazaki; Katsunori Yanagihara
International journal of hematology, 112, 3, 300, 306, 2020年09月, [国内誌]
英語, 研究論文(学術雑誌), Approximately 10-20 million of Human T-cell leukemia virus type-1 (HTLV-1)-infected carriers have been previously reported, and approximately 5% of these carriers develop adult T-cell leukemia/lymphoma (ATL) with a characteristic poor prognosis. In Japan, Southern blotting has long been routinely performed for detection of clonally expanded ATL cells in vivo, and as a confirmatory diagnostic test for ATL. However, alternative methods to Southern blotting, such as sensitive, quantitative, and rapid analytical methods, are currently required in clinical practice. In this study, we developed a high-throughput method called rapid amplification of integration site (RAIS) that could amplify HTLV-1-integrated fragments within 4 h and detect the integration sites in > 0.16% of infected cells. Furthermore, we established a novel quantification method for HTLV-1 clonality using Sanger sequencing with RAIS products, and the validity of the quantification method was confirmed by comparing it with next-generation sequencing in terms of the clonality. Thus, we believe that RAIS has a high potential for use as an alternative routine molecular confirmatory test for the clonality analysis of HTLV-1-infected cells. - Recent Molecular Evolution of Human Metapneumovirus (HMPV): Subdivision of HMPV A2b Strains.
Naganori Nao; Miwako Saikusa; Ko Sato; Tsuyoshi Sekizuka; Shuzo Usuku; Nobuko Tanaka; Hidekazu Nishimura; Makoto Takeda
Microorganisms, 8, 9, 2020年08月21日, [国際誌]
英語, 研究論文(学術雑誌), Human metapneumovirus (HMPV) is a major etiological agent of acute respiratory infections in humans. HMPV has been circulating worldwide for more than six decades and is currently divided into five agreed-upon subtypes: A1, A2a, A2b, B1, and B2. Recently, the novel HMPV subtypes A2c, A2b1, and A2b2 have been proposed. However, the phylogenetic and evolutionary relationships between these recently proposed HMPV subtypes are unclear. Here, we report a genome-wide phylogenetic and evolutionary analysis of 161 HMPV strains, including unique HMPV subtype A2b strains with a 180- or 111-nucleotide duplication in the G gene (nt-dup). Our data demonstrate that the HMPV A2b subtype contains two distinct subtypes, A2b1 and A2b2, and that the HMPV subtypes A2c and A2b2 may be different names for the same subtype. HMPV A2b strains with a nt-dup also belong to subtype A2b2. Molecular evolutionary analyses indicate that subtypes A2b1 and A2b2 diverged from subtype A2b around a decade after the subtype A2 was divided into the subtypes A2a and A2b. These data support the A2b1 and A2b2 subtypes proposed in 2012 and are essential for the unified classification of HMPV subtype A2 strains, which is important for future HMPV surveillance and epidemiological studies. - Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak.
Tsuyoshi Sekizuka; Kentaro Itokawa; Tsutomu Kageyama; Shinji Saito; Ikuyo Takayama; Hideki Asanuma; Naganori Nao; Rina Tanaka; Masanori Hashino; Takuri Takahashi; Hajime Kamiya; Takuya Yamagishi; Kensaku Kakimoto; Motoi Suzuki; Hideki Hasegawa; Takaji Wakita; Makoto Kuroda
Proceedings of the National Academy of Sciences of the United States of America, 117, 33, 20198, 20201, 2020年07月28日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), The Diamond Princess cruise ship was put under quarantine offshore Yokohama, Japan, after a passenger who disembarked in Hong Kong was confirmed as a coronavirus disease 2019 case. We performed whole-genome sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly from PCR+ clinical specimens and conducted a phylogenetic analysis of the outbreak. All tested isolates exhibited a transversion at G11083T, suggesting that SARS-CoV-2 dissemination on the Diamond Princess originated from a single introduction event before the quarantine started. Although further spreading might have been prevented by quarantine, some progeny clusters could be linked to transmission through mass-gathering events in the recreational areas and direct transmission among passengers who shared cabins during the quarantine. This study demonstrates the usefulness of haplotype network/phylogeny analysis in identifying potential infection routes. - Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan.
Kazuya Shirato; Naganori Nao; Harutaka Katano; Ikuyo Takayama; Shinji Saito; Fumihiro Kato; Hiroshi Katoh; Masafumi Sakata; Yuichiro Nakatsu; Yoshio Mori; Tsutomu Kageyama; Shutoku Matsuyama; Makoto Takeda
Japanese journal of infectious diseases, 73, 4, 304, 307, 2020年07月22日, [査読有り], [国内誌]
英語, 研究論文(学術雑誌), During the emergence of novel coronavirus 2019 (nCoV) outbreak in Wuhan city, China at the end of 2019, there was movement of many airline travelers between Wuhan and Japan, suggesting that the Japanese population was at high risk of infection by the virus. Hence, we urgently developed diagnostic systems for detection of 2019 nCoV. Two nested RT-PCR and two real-time RT-PCR assays were adapted for use in Japan. As of February 8, 2020, these assays have successfully detected 25 positive cases of infection in Japan. - Environmental sampling for severe acute respiratory syndrome coronavirus 2 during COVID-19 outbreak in the Diamond Princess cruise ship.
Takuya Yamagishi; Makoto Ohnishi; Nobuaki Matsunaga; Kensaku Kakimoto; Hajime Kamiya; Kiyoko Okamoto; Motoi Suzuki; Yoshiaki Gu; Mikiyo Sakaguchi; Taichi Tajima; Saho Takaya; Norio Ohmagari; Makoto Takeda; Syutoku Matsuyama; Kazuya Shirato; Naganori Nao; Hideki Hasegawa; Tsutomu Kageyama; Ikuyo Takayama; Shinji Saito; Koji Wada; Retsu Fujita; Hiroki Saito; Keiji Okinaka; Mathew Griffith; Amy Elizabeth Parry; Brenda Barnetson; James Leonard; Takaji Wakita
The Journal of infectious diseases, 222, 7, 1098, 1102, 2020年07月21日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), A COVID-19 outbreak occurred in the Diamond Princess cruise ship and we sampled environmental surfaces after passengers and crews vacated the cabins. SARS-CoV-2 RNA was detected from 58 out of 601 samples (10%) from case-cabins 1-17 days after the cabins were vacated, but not from non-case-cabins. There was no difference in the detection proportion between cabins for symptomatic (15%, 28/189, Cq: 29.79-38.86) and asymptomatic cases (21%, 28/131, Cq: 26.21-38.99). No SARS-CoV-2 virus was isolated from any of the samples. Transmission risk of SARS-CoV-2 from symptomatic and asymptomatic patients may be similar and environmental surfaces could be involved in viral transmission. - Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020.
Yuzo Arima; Tomoe Shimada; Motoi Suzuki; Tadaki Suzuki; Yusuke Kobayashi; Yuuki Tsuchihashi; Haruna Nakamura; Kaoru Matsumoto; Asuka Takeda; Keisuke Kadokura; Tetsuro Sato; Yuichiro Yahata; Noriko Nakajima; Minoru Tobiume; Ikuyo Takayama; Tsutomu Kageyama; Shinji Saito; Naganori Nao; Tamano Matsui; Tomimasa Sunagawa; Hideki Hasegawa; Makoto Ohnishi; Takaji Wakita
Emerging infectious diseases, 26, 7, 1596, 600, 2020年07月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), In early 2020, Japan repatriated 566 nationals from China. Universal laboratory testing and 14-day monitoring of returnees detected 12 cases of severe acute respiratory syndrome coronavirus 2 infection; initial screening results were negative for 5. Common outcomes were remaining asymptomatic (n = 4) and pneumonia (n = 6). Overall, screening performed poorly. - An ultra-rapid real-time RT-PCR method using the PCR1100 to detect Severe Acute Respiratory Syndrome Coronavirus-2.
Kazuya Shirato; Naganori Nao; Shutoku Matsuyama; Makoto Takeda; Tsutomu Kageyama
Japanese journal of infectious diseases, 2020年06月30日, [査読有り], [国内誌]
英語, 研究論文(学術雑誌), The disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) in Wuhan, China, in December 2019 is currently spreading rapidly worldwide. SARS-CoV-2 is usually detected via real-time RT-PCR. However, as institutions/hospitals deal with increasing numbers of specimens, a simpler detection system is required. Here, we present an ultra-rapid, real-time RT-PCR assay for SARS-CoV-2 using the PCR1100 device. Although this tests only one specimen at any one time, the amplification period is <20 min, with maintenance of the sensitivity and specificity of conventional real-time RT-PCR performed using large instruments. The method will be very helpful if SARS-CoV-2 testing is required a few times daily, for example to confirm virus-free status prior to discharge. - An ultra-rapid real-time RT-PCR method for detecting human orthopneumovirus using PCR1100.
Kazuya Shirato; Naganori Nao; Miyuki Kawase; Tsutomu Kageyama
Japanese journal of infectious diseases, 73, 6, 465, 468, 2020年05月29日, [査読有り], [国内誌]
英語, 研究論文(学術雑誌), Human orthopneumovirus, also known as the respiratory syncytial virus (RSV), is a leading cause of respiratory tract infections in children worldwide. The World Health Organization has taken steps toward establishing a global surveillance system for RSV, based on the global influenza surveillance and response system initiated in 2015. The US Center for Disease Control and Prevention (CDC) has developed a genetic detection method based on real-time RT-PCR, which is used in global RSV surveillance. In Japan, immunoassay-based rapid antigen detection kits are widely used for the detection of RSV. In this study, an ultra-rapid real-time RT-PCR method for the rapid detection of RSV was developed using the PCR1100 device based on the US CDC assay in order to detect RSV in comparable time to rapid test kits. The ultra-rapid real-time RT-PCR could detect RSV viral RNA in less than 20 min while maintaining sensitivity and specificity comparable to conventional real-time RT-PCR using large installed instruments. Furthermore, combining ultra-rapid real-time RT-PCR with the M1 Sample Prep kit reduced the total working time for the detection of RSV from clinical specimen to less than 25 min, suggesting this method could be used for point-of-care RSV testing. - Animal morbilliviruses and their cross-species transmission potential.
Makoto Takeda; Fumio Seki; Yuta Yamamoto; Naganori Nao; Hiroaki Tokiwa
Current opinion in virology, 41, 38, 45, 2020年04月25日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Like measles virus (MV), whose primary hosts are humans, non-human animal morbilliviruses use SLAM (signaling lymphocytic activation molecule) and PVRL4 (nectin-4) expressed on immune and epithelial cells, respectively, as receptors. PVRL4's amino acid sequence is highly conserved across species, while that of SLAM varies significantly. However, non-host animal SLAMs often function as receptors for different morbilliviruses. Uniquely, human SLAM is somewhat specific for MV, but canine distemper virus, which shows the widest host range among morbilliviruses, readily gains the ability to use human SLAM. The host range for morbilliviruses is also modulated by their ability to counteract the host's innate immunity, but the risk of cross-species transmission of non-human animal morbilliviruses to humans could occur if MV is successfully eradicated. - Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Shutoku Matsuyama; Naganori Nao; Kazuya Shirato; Miyuki Kawase; Shinji Saito; Ikuyo Takayama; Noriyo Nagata; Tsuyoshi Sekizuka; Hiroshi Katoh; Fumihiro Kato; Masafumi Sakata; Maino Tahara; Satoshi Kutsuna; Norio Ohmagari; Makoto Kuroda; Tadaki Suzuki; Tsutomu Kageyama; Makoto Takeda
Proceedings of the National Academy of Sciences of the United States of America, 117, 13, 7001, 7003, 2020年03月31日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused a large respiratory outbreak in Wuhan, China in December 2019, is currently spreading across many countries globally. Here, we show that a TMPRSS2-expressing VeroE6 cell line is highly susceptible to SARS-CoV-2 infection, making it useful for isolating and propagating SARS-CoV-2. Our results reveal that, in common with SARS- and Middle East respiratory syndrome-CoV, SARS-CoV-2 infection is enhanced by TMPRSS2. - An ultra-rapid real-time RT-PCR method for detecting Middle East respiratory syndrome coronavirus using a mobile PCR device, PCR1100.
Kazuya Shirato; Naganori Nao; Shutoku Matsuyama; Tsutomu Kageyama
Japanese journal of infectious diseases, 2019年12月25日, [査読有り], [国内誌]
英語, Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is usually diagnosed through highly sensitive and specific genetic tests such as real-time reverse transcription polymerase chain reaction (RT-PCR). Currently, two real-time RT-PCR assays targeting the upE and ORF1a regions of the MERS-CoV genome are widely used and are the standard assays recommended by the World Health Organization (WHO). The MERS outbreaks to date suggest that rapid diagnosis and subsequent isolation of infected patients, particularly superspreaders, are critical for containment. However, conventional real-time RT-PCR assays require large laboratory instruments, and amplification takes approximately 2 h. These are disadvantages for rapid diagnosis. Here, an ultra-rapid real-time RT-PCR test was established: a multiplex assay for upE and ORF1a running on the mobile PCR1100 device. As few as five copies of MERS-CoV RNA can be detected within 20 min using the WHO standard assays with similar sensitivity and specificity to those of a conventional real-time PCR instrument such as the LightCyler, enabling timely intervention to control MERS-CoV infection. - G遺伝子に重複配列を有するhuman metapneumovirus変異株の横浜市における動向
七種 美和子; 川上 千春; 宇宿 秀三; 直 亨則; 竹田 誠
日本小児感染症学会総会・学術集会プログラム・抄録集, 51回, 277, 277, 日本小児感染症学会, 2019年10月
日本語 - Predominant Detection of the Subgroup A2b Human Metapneumovirus Strain with a 111-Nucleotide Duplication in the G gene in Yokohama City, Japan in 2018.
Miwako Saikusa; Naganori Nao; Chiharu Kawakami; Shuzo Usuku; Nobuko Tanaka; Maino Tahara; Makoto Takeda; Ichiro Okubo
Japanese journal of infectious diseases, 72, 5, 350, 352, 2019年09月19日, [査読有り], [国内誌]
英語, Human metapneumovirus (HMPV) has been a major causative agent of acute respiratory infections in humans. Recently, two types of variant A2b subtype HMPV strains possessing a 111- or 180-nucleotide duplication (nt-dup) in the G gene (HMPV A2b180nt-dup and HMPV A2b111nt-dup, respectively) were detected in Japan, Spain, Vietnam, and China. Our surveillance for infectious agents in Yokohama City, Japan revealed that the HMPV A2b111nt-dup strain became predominant in Yokohama City in 2018. In contrast, no classic HMPV A2b strain was detected after 2017. These data indicate a beneficial role of the 111nt-dup in the G gene for the transmission of HMPV. - The R2TP complex regulates paramyxovirus RNA synthesis.
Hiroshi Katoh; Tsuyoshi Sekizuka; Yuichiro Nakatsu; Reiko Nakagawa; Naganori Nao; Masafumi Sakata; Fumihiro Kato; Makoto Kuroda; Minoru Kidokoro; Makoto Takeda
PLoS pathogens, 15, 5, e1007749, 2019年05月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), The regulation of paramyxovirus RNA synthesis by host proteins is poorly understood. Here, we identified a novel regulation mechanism of paramyxovirus RNA synthesis by the Hsp90 co-chaperone R2TP complex. We showed that the R2TP complex interacted with the paramyxovirus polymerase L protein and that silencing of the R2TP complex led to uncontrolled upregulation of mumps virus (MuV) gene transcription but not genome replication. Regulation by the R2TP complex was critical for MuV replication and evasion of host innate immune responses. The R2TP complex also regulated measles virus (MeV) RNA synthesis, but its function was inhibitory and not beneficial to MeV, as MeV evaded host innate immune responses in the absence of the R2TP complex. The identification of the R2TP complex as a critical host factor sheds new light on the regulation of paramyxovirus RNA synthesis. - Generation of bat-derived influenza viruses and their reassortants.
Masahiro Sato; Junki Maruyama; Tatsunari Kondoh; Naganori Nao; Hiroko Miyamoto; Yoshihiro Takadate; Wakako Furuyama; Masahiro Kajihara; Hirohito Ogawa; Rashid Manzoor; Reiko Yoshida; Manabu Igarashi; Ayato Takada
Scientific reports, 9, 1, 1158, 1158, 2019年02月04日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Two novel influenza A virus-like genomes were detected in fruit bats in Central and South America. However, the biological properties of these bat-derived influenza viruses (BatIVs) are still largely unknown since infectious viral particles have never been isolated from the infected host species. In this study, a reverse genetics approach was used to generate infectious BatIV particles entirely from plasmids encoding full-length sequences in eight gene segments. We inoculated BatIV particles into various cell cultures including bat-derived cell lines and found that BatIVs infected particular bat-derived cells efficiently but not the other cell lines tested. Reassortant viruses between the two BatIVs were also successfully generated and their replication in the susceptible bat cell lines was confirmed. These findings suggest a limited host range and reassortment potential of BatIVs in nature, providing fundamental information for understanding of the ecology of BatIVs. - Infection of newly identified phleboviruses in ticks and wild animals in Hokkaido, Japan indicating tick-borne life cycles.
Shiho Torii; Keita Matsuno; Yongjin Qiu; Akina Mori-Kajihara; Masahiro Kajihara; Ryo Nakao; Naganori Nao; Katsunori Okazaki; Mariko Sashika; Takahiro Hiono; Masatoshi Okamatsu; Yoshihiro Sakoda; Hideki Ebihara; Ayato Takada; Hirofumi Sawa
Ticks and tick-borne diseases, 10, 2, 328, 335, 2019年02月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Recent discoveries of tick-borne pathogens have raised public health concerns on tick-borne infectious diseases and emphasize the need to assess potential risks of unrecognized tick-borne pathogens. First, to determine the existence of tick-borne phleboviruses (TBPVs), genetic surveillance of phleboviruses in ticks was conducted mainly in Hokkaido, the northernmost island in Japan from 2013 to 2015. Genes of two TBPVs, previously reported as Mukawa virus (MKWV) and a newly identified relative of MKWV, Kuriyama virus (KURV), were detected and the viruses were isolated from Ixodes persulcatus collected in Hokkaido, but not in I. persulcatus collected from other areas of Japan. These viruses were phylogenetically and antigenically similar to each other. Next, to investigate the infection of MKWV in mammals, serum samples from wildlife captured in Hokkaido from 2007 to 2011 were used for serological screening. Neutralizing antibodies against MKWV were detected in both Yezo-deer (Cervus nippon yesoensis) (2/50) and raccoons (Procyon lotor) (16/64). However, no infectious MKWV was recovered from laboratory mice in experimental infections, though viral RNAs were detected in their tissues. Thus, MKWV and KURV may maintain tick-mammalian life cycles in Hokkaido, suggesting their potential as causative agents of tick-borne diseases in mammals. - Consensus and variations in cell line specificity among human metapneumovirus strains.
Naganori Nao; Ko Sato; Junya Yamagishi; Maino Tahara; Yuichiro Nakatsu; Fumio Seki; Hiroshi Katoh; Aiko Ohnuma; Yuta Shirogane; Masahiro Hayashi; Tamio Suzuki; Hideaki Kikuta; Hidekazu Nishimura; Makoto Takeda
PloS one, 14, 4, e0215822, 2019年, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Human metapneumovirus (HMPV) has been a notable etiological agent of acute respiratory infection in humans, but it was not discovered until 2001, because HMPV replicates only in a limited number of cell lines and the cytopathic effect (CPE) is often mild. To promote the study of HMPV, several groups have generated green fluorescent protein (GFP)-expressing recombinant HMPV strains (HMPVGFP). However, the growing evidence has complicated the understanding of cell line specificity of HMPV, because it seems to vary notably among HMPV strains. In addition, unique A2b clade HMPV strains with a 180-nucleotide duplication in the G gene (HMPV A2b180nt-dup strains) have recently been detected. In this study, we re-evaluated and compared the cell line specificity of clinical isolates of HMPV strains, including the novel HMPV A2b180nt-dup strains, and six recombinant HMPVGFP strains, including the newly generated recombinant HMPV A2b180nt-dup strain, MG0256-EGFP. Our data demonstrate that VeroE6 and LLC-MK2 cells generally showed the highest infectivity with any clinical isolates and recombinant HMPVGFP strains. Other human-derived cell lines (BEAS-2B, A549, HEK293, MNT-1, and HeLa cells) showed certain levels of infectivity with HMPV, but these were significantly lower than those of VeroE6 and LLC-MK2 cells. Also, the infectivity in these suboptimal cell lines varied greatly among HMPV strains. The variations were not directly related to HMPV genotypes, cell lines used for isolation and propagation, specific genome mutations, or nucleotide duplications in the G gene. Thus, these variations in suboptimal cell lines are likely intrinsic to particular HMPV strains. - Middle East Respiratory Syndrome Coronavirus in Dromedaries in Ethiopia Is Antigenically Different From the Middle East Isolate EMC.
Kazuya Shirato; Simenew Keskes Melaku; Kengo Kawachi; Naganori Nao; Naoko Iwata-Yoshikawa; Miyuki Kawase; Wataru Kamitani; Shutoku Matsuyama; Tesfaye Sisay Tessema; Hiroshi Sentsui
Frontiers in microbiology, 10, 1326, 1326, 2019年, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Middle East respiratory syndrome (MERS) is an emerging respiratory disease caused by the MERS coronavirus (MERS-CoV). MERS has been endemic to Saudi Arabia since 2012. The reservoir of MERS-CoV is the dromedary camel, suggesting that MERS is primarily a zoonotic disease. MERS-CoV is common in dromedaries throughout the Middle East, North Africa, and East Africa as evidenced by neutralizing antibodies against MERS-CoV; however, human cases have remained limited to the Middle East. To better understand the cause of this difference, the virological properties of African camel MERS-CoV were analyzed based on the spike (S) protein in Ethiopia. Nasal swabs were collected from 258 young dromedaries (≤ 2 years old) in the Afar region of Ethiopia, of which 39 were positive for MERS-CoV, as confirmed by genetic tests. All positive tests were exclusive to the Amibara woreda region. Using next-generation sequencing, two full-length genomes of Amibara isolates were successfully decoded; both isolates belonged to the C2 clade based on phylogenetic analysis of full-length and S protein sequences. Recombinant EMC isolates of MERS-CoV, in which the S protein is replaced with those of Amibara isolates, were then generated to test the roles of these proteins in viral properties. Amibara S recombinants replicated more slowly in cultured cells than in EMC S recombinants. In neutralizing assays, Amibara S recombinants were neutralized by lower concentrations of sera from both Ethiopian dromedaries and EMC isolate (wild-type)-immunized mouse sera, relative to the EMC S recombinants, indicating that viruses coated in the Amibara S protein were easier to neutralize than the EMC S protein. Neutralization experiments performed using S1/S2 chimeric recombinants of the EMC and Amibara S proteins showed that the neutralization profile was dependent on the S1 region of the S protein. These results suggest that the slower viral replication and the ease of neutralization seen in the Ethiopian MERS-CoV are due to strain-specific differences in the S protein and may account for the absence of human MERS-CoV cases in Ethiopia. - The Unique Phylogenetic Position of a Novel Tick-Borne Phlebovirus Ensures an Ixodid Origin of the Genus Phlebovirus.
Keita Matsuno; Masahiro Kajihara; Ryo Nakao; Naganori Nao; Akina Mori-Kajihara; Mieko Muramatsu; Yongjin Qiu; Shiho Torii; Manabu Igarashi; Nodoka Kasajima; Keita Mizuma; Kentaro Yoshii; Hirofumi Sawa; Chihiro Sugimoto; Ayato Takada; Hideki Ebihara
mSphere, 3, 3, 2018年06月27日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), The recent emergence of novel tick-borne RNA viruses has complicated the epidemiological landscape of tick-borne infectious diseases, posing a significant challenge to public health systems that seek to counteract tick-borne diseases. The identification of two novel tick-borne phleboviruses (TBPVs), severe fever with thrombocytopenia syndrome virus (SFTSV) and Heartland virus (HRTV), as causative agents of severe illness in humans has accelerated the investigation and discoveries of novel TBPVs. In the present study, we isolated a novel TBPV designated Mukawa virus (MKWV) from host-questing Ixodes persulcatus females captured in Japan. Genetic characterization revealed that MKWV is a member of the genus Phlebovirus in the family Phenuiviridae Interestingly, MKWV is genetically distinct from other known TBPVs and shares a most recent common ancestor with mosquito/sandfly-borne (insect-borne) phleboviruses. Despite its genetic similarity to insect-borne phleboviruses, the molecular footprints of its viral proteins and its biological characteristics define MKWV as a tick-borne virus that can be transmitted to mammals. A phylogenetic ancestral-state reconstruction for arthropod vectors of phleboviruses including MKWV based on viral L segment sequences indicated that ticks likely harbored ancestral phleboviruses that evolved into both the tick-borne and MKWV/insect-borne phlebovirus lineages. Overall, our findings suggest that most of the phlebovirus evolution has occurred in hard ticks to generate divergent viruses, which may provide a seminal foundation for understanding the mechanisms underlying the evolution and emergence of pathogenic phleboviruses, such as Rift Valley fever virus and SFTSV/HRTV.IMPORTANCE The emergence of novel tick-borne RNA viruses causing severe illness in humans has complicated the epidemiological landscape of tick-borne diseases, requiring further investigation to safeguard public health. In the present study, we discovered a novel tick-borne phlebovirus from Ixodes persulcatus ticks in Japan. While its viral RNA genome sequences were similar to those of mosquito/sandfly-borne viruses, molecular and biological footprints confirmed that this is a tick-borne virus. The unique evolutionary position of the virus allowed us to estimate the ancestral phlebovirus vector, which was likely a hard tick. Our findings may provide a better understanding of the evolution and emergence of phleboviruses associated with emerging infectious diseases, such as severe fever with thrombocytopenia syndrome (SFTS) and Heartland virus disease. - Characterization of a Novel Bat Adenovirus Isolated from Straw-Colored Fruit Bat (Eidolon helvum).
Hirohito Ogawa; Masahiro Kajihara; Naganori Nao; Asako Shigeno; Daisuke Fujikura; Bernard M Hang'ombe; Aaron S Mweene; Alisheke Mutemwa; David Squarre; Masao Yamada; Hideaki Higashi; Hirofumi Sawa; Ayato Takada
Viruses, 9, 12, 2017年12月04日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Bats are important reservoirs for emerging zoonotic viruses. For extensive surveys of potential pathogens in straw-colored fruit bats (Eidolon helvum) in Zambia, a total of 107 spleen samples of E. helvum in 2006 were inoculated onto Vero E6 cells. The cell culture inoculated with one of the samples (ZFB06-106) exhibited remarkable cytopathic changes. Based on the ultrastructural property in negative staining and cross-reactivity in immunofluorescence assays, the virus was suspected to be an adenovirus, and tentatively named E. helvum adenovirus 06-106 (EhAdV 06-106). Analysis of the full-length genome of 30,134 bp, determined by next-generation sequencing, showed the presence of 28 open reading frames. Phylogenetic analyses confirmed that EhAdV 06-106 represented a novel bat adenovirus species in the genus Mastadenovirus. The virus shared similar characteristics of low G + C contents with recently isolated members of species Bat mastadenoviruses E, F and G, from which EhAdV 06-106 diverged by more than 15% based on the distance matrix analysis of DNA polymerase amino acid sequences. According to the taxonomic criteria, we propose the tentative new species name "Bat mastadenovirus H". Because EhAdV 06-106 exhibited a wide in vitro cell tropism, the virus might have a potential risk as an emerging virus through cross-species transmission. - A novel 111-nucleotide duplication in the G gene of human metapneumovirus.
Miwako Saikusa; Naganori Nao; Chiharu Kawakami; Shuzo Usuku; Tadayoshi Sasao; Takahiro Toyozawa; Makoto Takeda; Ichiro Okubo
Microbiology and immunology, 61, 11, 507, 512, 2017年11月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌) - Genetic Predisposition To Acquire a Polybasic Cleavage Site for Highly Pathogenic Avian Influenza Virus Hemagglutinin.
Naganori Nao; Junya Yamagishi; Hiroko Miyamoto; Manabu Igarashi; Rashid Manzoor; Aiko Ohnuma; Yoshimi Tsuda; Wakako Furuyama; Asako Shigeno; Masahiro Kajihara; Noriko Kishida; Reiko Yoshida; Ayato Takada
mBio, 8, 1, 2017年02月14日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌) - 180-Nucleotide Duplication in the G Gene of Human metapneumovirus A2b Subgroup Strains Circulating in Yokohama City, Japan, since 2014.
Miwako Saikusa; Chiharu Kawakami; Naganori Nao; Makoto Takeda; Shuzo Usuku; Tadayoshi Sasao; Kimiko Nishimoto; Takahiro Toyozawa
Frontiers in microbiology, 8, 402, 402, 2017年, [査読有り], [国際誌]
英語, 研究論文(学術雑誌) - Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor.
Tatsunari Kondoh; Rashid Manzoor; Naganori Nao; Junki Maruyama; Wakako Furuyama; Hiroko Miyamoto; Asako Shigeno; Makoto Kuroda; Keita Matsuno; Daisuke Fujikura; Masahiro Kajihara; Reiko Yoshida; Manabu Igarashi; Ayato Takada
PloS one, 12, 10, e0186450, 2017年, [査読有り], [国際誌]
英語, 研究論文(学術雑誌) - Putative RNA viral sequences detected in an Ixodes scapularis-derived cell line.
Ryo Nakao; Keita Matsuno; Yongjin Qiu; Junki Maruyama; Nao Eguchi; Naganori Nao; Masahiro Kajihara; Kentaro Yoshii; Hirofumi Sawa; Ayato Takada; Chihiro Sugimoto
Ticks and tick-borne diseases, 8, 1, 103, 111, 2017年01月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌) - Characterization of the glycoproteins of bat-derived influenza viruses.
Junki Maruyama; Naganori Nao; Hiroko Miyamoto; Ken Maeda; Hirohito Ogawa; Reiko Yoshida; Manabu Igarashi; Ayato Takada
Virology, 488, 43, 50, 2016年01月15日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Recently found bat-derived influenza viruses (BatIVs) have hemagglutinin (HA) and neuraminidase (NA) gene segments distinct from those of previously known influenza A viruses. However, pathogenicities of these BatIVs remain unknown since infectious virus strains have not been isolated yet. To gain insight into the biological properties of BatIVs, we generated vesicular stomatitis viruses (VSVs) pseudotyped with the BatIV HA and NA. We found that VSVs pseudotyped with BatIV HAs and NAs efficiently infected particular bat cell lines but not those derived from primates, and that proteolytic cleavage with a trypsin-like protease was necessary for HA-mediated virus entry. Treatment of the susceptible bat cells with some enzymes and inhibitors revealed that BatIV HAs might recognize some cellular glycoproteins as receptors rather than the sialic acids used for the other known influenza viruses. These data provide fundamental information on the mechanisms underlying the cellular entry and host restriction of BatIVs. - Seroepidemiological Prevalence of Multiple Species of Filoviruses in Fruit Bats (Eidolon helvum) Migrating in Africa.
Hirohito Ogawa; Hiroko Miyamoto; Eri Nakayama; Reiko Yoshida; Ichiro Nakamura; Hirofumi Sawa; Akihiro Ishii; Yuka Thomas; Emiko Nakagawa; Keita Matsuno; Masahiro Kajihara; Junki Maruyama; Naganori Nao; Mieko Muramatsu; Makoto Kuroda; Edgar Simulundu; Katendi Changula; Bernard Hang'ombe; Boniface Namangala; Andrew Nambota; Jackson Katampi; Manabu Igarashi; Kimihito Ito; Heinz Feldmann; Chihiro Sugimoto; Ladslav Moonga; Aaron Mweene; Ayato Takada
The Journal of infectious diseases, 212 Suppl 2, S101-8, 8, 2015年10月01日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Fruit bats are suspected to be a natural reservoir of filoviruses, including Ebola and Marburg viruses. Using an enzyme-linked immunosorbent assay based on the viral glycoprotein antigens, we detected filovirus-specific immunoglobulin G antibodies in 71 of 748 serum samples collected from migratory fruit bats (Eidolon helvum) in Zambia during 2006-2013. Although antibodies to African filoviruses (eg, Zaire ebolavirus) were most prevalent, some serum samples showed distinct specificity for Reston ebolavirus, which that has thus far been found only in Asia. Interestingly, the transition of filovirus species causing outbreaks in Central and West Africa during 2005-2014 seemed to be synchronized with the change of the serologically dominant virus species in these bats. These data suggest the introduction of multiple species of filoviruses in the migratory bat population and point to the need for continued surveillance of filovirus infection of wild animals in sub-Saharan Africa, including hitherto nonendemic countries. - Genetic and antigenic characterization of H5 and H7 influenza viruses isolated from migratory water birds in Hokkaido, Japan and Mongolia from 2010 to 2014.
Takahiro Hiono; Ayako Ohkawara; Kohei Ogasawara; Masatoshi Okamatsu; Tomokazu Tamura; Duc-Huy Chu; Mizuho Suzuki; Saya Kuribayashi; Shintaro Shichinohe; Ayato Takada; Hirohito Ogawa; Reiko Yoshida; Hiroko Miyamoto; Naganori Nao; Wakako Furuyama; Junki Maruyama; Nao Eguchi; Gerelmaa Ulziibat; Bazarragchaa Enkhbold; Munkhduuren Shatar; Tserenjav Jargalsaikhan; Selenge Byambadorj; Batchuluun Damdinjav; Yoshihiro Sakoda; Hiroshi Kida
Virus genes, 51, 1, 57, 68, 2015年08月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Migratory water birds are the natural reservoir of influenza A viruses. H5 and H7 influenza viruses are isolated over the world and also circulate among poultry in Asia. In 2010, two H5N1 highly pathogenic avian influenza viruses (HPAIVs) were isolated from fecal samples of water birds on the flyway of migration from Siberia, Russia to the south in Hokkaido, Japan. H7N9 viruses are sporadically isolated from humans and circulate in poultry in China. To monitor whether these viruses have spread in the wild bird population, we conducted virological surveillance of avian influenza in migratory water birds in autumn from 2010 to 2014. A total of 8103 fecal samples from migratory water birds were collected in Japan and Mongolia, and 350 influenza viruses including 13 H5 and 19 H7 influenza viruses were isolated. A phylogenetic analysis revealed that all isolates are genetically closely related to viruses circulating among wild water birds. The results of the antigenic analysis indicated that the antigenicity of viruses in wild water birds is highly stable despite their nucleotide sequence diversity but is distinct from that of HPAIVs recently isolated in Asia. The present results suggest that HPAIVs and Chinese H7N9 viruses were not predominantly circulating in migratory water birds; however, continued monitoring of H5 and H7 influenza viruses both in domestic and wild birds is recommended for the control of avian influenza. - A Single Amino Acid in the M1 Protein Responsible for the Different Pathogenic Potentials of H5N1 Highly Pathogenic Avian Influenza Virus Strains.
Naganori Nao; Masahiro Kajihara; Rashid Manzoor; Junki Maruyama; Reiko Yoshida; Mieko Muramatsu; Hiroko Miyamoto; Manabu Igarashi; Nao Eguchi; Masahiro Sato; Tatsunari Kondoh; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida; Ayato Takada
PloS one, 10, 9, e0137989, 2015年, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Two highly pathogenic avian influenza virus strains, A/duck/Hokkaido/WZ83/2010 (H5N1) (WZ83) and A/duck/Hokkaido/WZ101/2010 (H5N1) (WZ101), which were isolated from wild ducks in Japan, were found to be genetically similar, with only two amino acid differences in their M1 and PB1 proteins at positions 43 and 317, respectively. We found that both WZ83 and WZ101 caused lethal infection in chickens but WZ101 killed them more rapidly than WZ83. Interestingly, ducks experimentally infected with WZ83 showed no or only mild clinical symptoms, whereas WZ101 was highly lethal. We then generated reassortants between these viruses and found that exchange of the M gene segment completely switched the pathogenic phenotype in both chickens and ducks, indicating that the difference in the pathogenicity for these avian species between WZ83 and WZ101 was determined by only a single amino acid in the M1 protein. It was also found that WZ101 showed higher pathogenicity than WZ83 in mice and that WZ83, whose M gene was replaced with that of WZ101, showed higher pathogenicity than wild-type WZ83, although this reassortant virus was not fully pathogenic compared to wild-type WZ101. These results suggest that the amino acid at position 43 of the M1 protein is one of the factors contributing to the pathogenicity of H5N1 highly pathogenic avian influenza viruses in both avian and mammalian hosts. - The zoonotic potential of avian influenza viruses isolated from wild waterfowl in Zambia.
Edgar Simulundu; Naganori Nao; John Yabe; Nilton A Muto; Thami Sithebe; Hirofumi Sawa; Rashid Manzoor; Masahiro Kajihara; Mieko Muramatsu; Akihiro Ishii; Hirohito Ogawa; Aaron S Mweene; Ayato Takada
Archives of virology, 159, 10, 2633, 40, 2014年10月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌) - Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity.
Mieko Muramatsu; Reiko Yoshida; Ayaka Yokoyama; Hiroko Miyamoto; Masahiro Kajihara; Junki Maruyama; Naganori Nao; Rashid Manzoor; Ayato Takada
PloS one, 9, 1, e85582, 2014年, [査読有り], [国際誌]
英語, 研究論文(学術雑誌)
- 母子ともにリンパ腫を呈した牛におけるRAISING法を用いたクローナリティ解析
廣瀬海凪; 岡川朋弘; 岡川朋弘; 斎藤益満; 松平崇弘; 直亨則; 前川直也; 村田史郎; 大橋和彦; 今内覚; 今内覚, 日本獣医学会学術集会講演要旨集, 168th, 2025年 - 北海道東部における海鳥と海棲哺乳動物からのH5N1亜型高病原性鳥インフルエンザウイルスの検出
日尾野隆大; 直亨則; 渡邊有希子; 市川世識; 服部薫; 外山雅大; LIM Hew Yik; 磯田典和; 松野啓太; 大沼学; 迫田義博, 日本獣医学会学術集会講演要旨集, 168th, 2025年 - 国内におけるカラスオルソレオウイルスによるカラス大量死事例
市川世識; 鈴木玲海; PAU Valcorza; 後藤拓磨; 古田若葉; 日尾野隆大; 日尾野隆大; 直亨則; 直亨則; 佐藤豊孝; 佐藤豊孝; 池中良徳; 池中良徳; 石塚真由美; 石塚真由美; 青島圭佑; 青島圭佑; 木村享史, 北海道獣医師会雑誌, 69, 8, 2025年 - 北海道大学における野生動物死因究明への取り組み
直亨則; 日尾野隆大; 青島圭佑; 市川世識; 大谷祐紀; 佐藤豊孝; 池中良徳; 松野啓太; 堀内基広; 直亨則; 日尾野隆大; 青島圭佑; 大谷祐紀; 佐藤豊孝; 池中良徳; 松野啓太; 堀内基広, 日本獣医学会学術集会講演要旨集, 168th, 2025年 - 2024~2025年における野鳥および海生哺乳類のHPAIV感染の確認とモニタリング体制で見えてきた課題
渡辺有希子; 安達光; 服部薫; 松野啓太; 日尾野隆大; 日尾野隆大; 直亨則; 磯田典和; 磯田典和; 迫田義博; 迫田義博; 大沼学; 齊藤慶輔, 北海道獣医師会雑誌, 69, 8, 2025年 - 新型コロナ流行後 再興した感染症:世界と日本 ヒトメタニューモウイルス
直亨則; 直亨則; 直亨則; 竹田誠, 臨床とウイルス, 53, 2, 2025年 - 様々なスパイクタンパク質に置換したC57BL/6マウス馴化SARS-CoV-2の比較解析
鈴木理滋; 鈴木理滋; 辻野修平; 王磊; 伊藤駿; 鈴木紗織; 鈴木紗織; 田村友和; 田村友和; 田村友和; 直亨則; 直亨則; 松野啓太; 松野啓太; 田中伸哉; 福原崇介; 福原崇介; 福原崇介; 福原崇介, 日本ウイルス学会学術集会プログラム・予稿集(Web), 71st, 2024年 - 人獣共通感染症対策に資する活動
澤洋文; 澤洋文; 澤洋文; 田畑耕史郎; 板倉友香里; 梶原将大; 林田京子; 松野啓太; 直亨則; 大場靖子; 大場靖子; 佐々木道仁, 日本化学療法学会雑誌, 72, 5, 2024年 - 株間ゲノム比較によるネルソンベイオルソレオウイルスの新規病原性因子の同定
播磨勇人; 佐々木道仁; 有泉拓馬; 川口虹穂; 小林広子; KITTIYA Intaruck; 小林剛; 川岸崇裕; 金井祐太; 直亨則; 邱永晋; 梶原将大; 大場靖子; 伊藤直人; 石原加奈子; HANGOMBE Bernard M; 澤洋文, 日本ウイルス学会学術集会プログラム・予稿集(Web), 71st, 2024年 - RAISING法を用いたネコ白血病ウイルスの挿入位置決定技術の開発
佐藤真; 久保田渉誠; 相原浩揮; 直亨則; 斎藤益満; 中村健介; 山崎淳平; 松平崇弘, 日本獣医学会学術集会講演要旨集, 167th, 2024年 - ヒトオルガノイドおよびハムスターモデルを用いたSARS-CoV-2関連コウモリコロナウイルスであるBANAL-20-236のウイルス学的性状解析
藤田滋; PLIANCHAISUK Arnon; 出口清香; 伊藤駿; 直亨則; 王磊; NASSER Hesham; 田村友和; 木村出海; 鹿島幸恵; 鈴木理滋; 鈴木紗織; 紀田泉; 津田真寿美; 小田義崇; 橋本里菜; 渡邉幸夫; 瓜生慧也; 山岨大智; 郭子毅; HINAY Alfredo Jr.; 小杉優介; 陳犖; 潘琳; 郭悠; 山本祐樹; 永元哲治; 長島真美; 浅倉弘幸; 貞升健志; 吉村和久; 鈴木穣; 伊東潤平; 池田輝政; 田中伸哉; 松野啓太; 福原崇介; 高山和雄; 佐藤佳, 日本獣医学会学術集会講演要旨集, 167th, 2024年 - 非典型的な地方病性牛伝染性リンパ腫症例のRAISING法を用いた性状解析
松原幸芽; 岡川朋弘; 斎藤益満; 松平崇弘; 直亨則; 神谷可菜; 齋藤麻矢; 前川直也; 村田史郎; 大橋和彦; 今内覚, 日本獣医学会学術集会講演要旨集, 167th, 2024年 - 新型コロナウイルスオミクロン亜株のモデル動物ハムスターにおける病原性
田村友和; 田村友和; 伊東潤平; 鈴木理滋; 鈴木理滋; 直亨則; 小田義崇; 瓜生慧也; 伊藤駿; 王磊; 紀田泉; 板倉友香里; 板倉友香里; 津田真寿美; 鈴木紗織; 鈴木紗織; 松野啓太; 松野啓太; 田中伸哉; 佐藤佳; 福原崇介; 福原崇介; 福原崇介, 日本ウイルス学会学術集会プログラム・予稿集(Web), 70th, 2023年 - マールブルグウイルスおよびエジプトルーセットオオコウモリの生態学的調査
梶原将大; 藤岡慧明; CHANGULA Katendi; 邱永晋; 梶原亜紀奈; 手嶋優風; NDEBE Joseph; MOONGA Ladslav; 直亨則; 直亨則; 尾針由真; 林田京子; HANG’OMBE Bernard M; 川端寛樹; 澤洋文; 澤洋文; 澤洋文; 飛龍志津子; 高田礼人; 高田礼人, 日本ウイルス学会学術集会プログラム・予稿集(Web), 70th, 2023年 - B型肝炎ウイルスゲノム挿入の新規検出技術を応用した肝がん再発予測マーカーの開発
深野顕人; 深野顕人; 若江亨祥; 直亨則; 直亨則; 斎藤益満; 斎藤益満; 豊嶋孝恵; 坪田昭人; 相崎英樹; 松平崇弘; 木村基; 渡士幸一; 渡士幸一; 杉浦亙; 村松正道; 村松正道, 日本ウイルス学会学術集会プログラム・予稿集(Web), 70th, 2023年 - 肝発癌へ寄与するB型肝炎ウイルスゲノム挿入の新規検出法の確立
深野顕人; 深野顕人; 若江亨祥; 直亨則; 斎藤益満; 豊嶋孝恵; 坪田昭人; 相崎英樹; 松平崇弘; 木村基; 渡士幸一; 杉浦亙; 村松正道, 日本薬学会年会要旨集(Web), 143rd, 2023年 - B型肝炎ウイルスゲノム挿入の新規検出法の確立
深野顕人; 深野顕人; 若江亨祥; 直亨則; 斎藤益満; 斎藤益満; 豊嶋孝恵; 坪田昭人; 相崎英樹; 松平崇弘; 木村基; 渡士幸一; 渡士幸一; 杉浦亙; 村松正道, 日本ウイルス学会学術集会プログラム・予稿集(Web), 69th, 2022年 - SARS-CoV-2BA.2株に由来する亜株の性状解析
木村出海; 山岨大智; 山岨大智; 田村友和; 直亨則; 直亨則; 伊東潤平; 松野啓太; 松野啓太; 松野啓太; 澤洋文; 澤洋文; 澤洋文; 福原崇介; 佐藤佳, 日本ウイルス学会学術集会プログラム・予稿集(Web), 69th, 2022年 - 近年のHMPVの分子進化とA2亜型の細分類
直亨則; 直亨則; 七種美和子; 佐藤光; 関塚剛史; 宇宿秀三; 田中伸子; 西村秀一; 竹田誠, 日本ウイルス学会学術集会プログラム・予稿集(Web), 68th, 2021年 - G遺伝子に重複配列を有するhuman metapneumovirus変異株の横浜市における動向
七種 美和子; 川上 千春; 宇宿 秀三; 直 亨則; 竹田 誠, 日本小児感染症学会総会・学術集会プログラム・抄録集, 51回, 277, 277, 2019年10月
日本小児感染症学会, 日本語 - 培養細胞への感染性におけるヒトメタニューモウイルス株間の一致と差異
竹田 誠; 直 亨則; 佐藤 光; 西村 秀一, 日本小児感染症学会総会・学術集会プログラム・抄録集, 51回, 142, 142, 2019年10月
日本小児感染症学会, 日本語 - CRISPR/Cas9ゲノムワイドライブラリーを用いたニューモウイルス関連宿主因子探索
直亨則; 山地俊之; 関塚剛史; 白戸憲也; 竹田誠, 日本ウイルス学会学術集会プログラム・予稿集(Web), 67th, 2019年 - ヒトメタニューモウイルス株の感染性に関する解析
竹田 誠; 關 文緒; 直 亨則, 日本小児科学会雑誌, 122, 2, 220, 220, 2018年02月
(公社)日本小児科学会, 日本語 - 横浜市において検出されたhuman metapneumovirusの遺伝子解析:G遺伝子に111塩基の重複配列を持つ株の流行について
七種美和子; 川上千春; 宇宿秀三; 笹尾忠由; 豊澤隆弘; 直亨則; 竹田誠, 日本小児感染症学会総会・学術集会プログラム・抄録集, 49th, 243, 2017年
日本語 - ザンビア共和国に飛来するストローオオコウモリ(Eidolon helvum)から分離されたアデノウイルスの性状解析と分子疫学的解析
小川寛人; 小川寛人; 小川寛人; 梶原将大; 直亨則; 丸山隼輝; 上野恵介; 石井秋宏; 石井秋宏; 藤倉大輔; HANG’OMBE Bernard; AARON Mweene; 山田雅夫; 東秀明; 東秀明; 澤洋文; 澤洋文; 高田礼人; 高田礼人, 日本獣医学会学術集会講演要旨集, 159th, 376, 376, 2016年08月30日
(公社)日本獣医学会, 日本語 - 下腹部の角化性腫瘤
椎谷千尋; 月永一郎; 清水亜衣; 直亨則; 岩崎沙理; 秦洋郎; 阿南隆; 熊切正信, 日本皮膚病理組織学会抄録集, 32nd, 35 (JA),15 (EN), 35, 2016年
日本皮膚病理組織学会, 日本語 - 北海道で分離された新規ダニ媒介性フレボウイルスの性状解析
鳥居志保; 鳥居志保; 松野啓太; 松野啓太; 中尾亮; 邱永晋; 梶原将大; 直亨則; 村松美笑子; 海老原秀喜; 高田礼人; 高田礼人, 日本分子生物学会年会プログラム・要旨集(Web), 39th, ROMBUNNO.1LBA‐083 (WEB ONLY), 2016年
日本語 - 平成25年臨床病理検討会(剖検検討会)記録
斎藤俊一; 藤澤孝志; 萩尾加奈子; 佐藤大樹; 直亨則; 伊東直史; 西浦洋一; 冨塚晶子; 小島哲弥; 大田拓児; 岩崎沙理; 斎藤拓志; 伊藤健一郎; 伊藤聡司; 鈴木昭; 大槻雄士; 市川隆裕, KKR札幌医療センター医学雑誌, 11, 1, 84, 93, 2014年10月
日本語 - 北海道産マダニからの新規フレボウイルスの検出
中尾 亮; 梶原 将大; 邱 永晋; 森 亜紀奈; 直 亨則; 村松 美笑子; 好井 健太朗; 苅和 宏明; 澤 洋文; 杉本 千尋; 高田 礼人, 日本獣医学会学術集会講演要旨集, 157回, 451, 451, 2014年08月
(公社)日本獣医学会, 日本語 - 2010年に稚内で分離された2株の高病原性鳥インフルエンザウイルスの病原性比較
直亨則; 梶原将大; 丸山隼輝; 木村享史; MANZOOR Rashid; 村松美笑子; 岡松正敏; 宮本洋子; 吉田玲子; 迫田義博; 喜田宏; 高田礼人, 日本ウイルス学会学術集会プログラム・抄録集, 61st, 150, 2013年10月29日
日本語 - 劇症型A群β血連鎖球菌感染症と類似の組織像を示した黄色ブドウ球菌感染症の一剖検例
直亨則; 柳内充; 伊丹弘恵; 辻隆裕; 深澤雄一郎, 日本病理学会会誌, 102, 1, 434, 2013年04月26日
日本語 - 富粘液型への移行を疑わせた多形腺腫由来唾液腺導管癌の一例
大内知之; 小山田ゆみ子; 大森優子; 鈴木昭; 岩崎沙理; 直亨則; 深澤雄一郎; 近藤信夫, 日本唾液腺学会誌, 53, 41, 2012年11月10日
日本語 - 紡錘形の細胞状態を示した非定型的肺カルチノイド腫瘍の1例
今川誠; 水上恵子; 小田由紀子; 朝日久仁子; 目黒祐二; 土田幸弘; 磯部宏; 藤澤孝志; 直亨則; 岩崎沙理; 鈴木昭, 日本臨床細胞学会北海道支部会報, 21, 48, 51, 2012年10月05日
日本語 - 第32回日本臨床細胞学会北海道支部学術集会スライドセミナー(3)総合科系
鈴木昭; 岩崎沙理; 藤澤孝志; 直亨則; 今川誠; 朝日久仁子; 水上恵子; 小田由紀子; 目黒祐二, 日本臨床細胞学会北海道支部会報, 21, 81, 84, 2012年10月05日
日本語 - 致死的経過をとったアデノウイルス37型による新生児重症肺炎の1例
津曲俊太郎; 工藤絵理子; 佐々木大輔; 簗詰紀子; 縄手満; 吉岡幹朗; 鹿野高明; 高橋豊; 直亨則; 鈴木昭; 佐多徹太郎; 梶原将大, 日本小児科学会雑誌, 116, 5, 940, 2012年05月01日
日本語 - 新生児に致死的肺炎を引き起こしたアデノウイルスの解析
直亨則; 津曲俊太郎; 吉岡幹郎; 梶原将大; 鈴木昭; 高橋豊; 高田礼人, 日本ウイルス学会北海道支部夏季シンポジウム講演抄録, 46th, 10, 2012年
日本語
- ヒトメタニューモウイルスの治療・予防法開発を目指した基盤研究
科学研究費助成事業
2025年04月01日 - 2029年03月31日
直 亨則
日本学術振興会, 基盤研究(C), 北海道大学, 25K11734 - ヒトメタニューモウイルスによる宿主自然免疫ハイジャック機構の解明
科学研究費助成事業
2020年04月01日 - 2023年03月31日
直 亨則
インターフェロン誘導因子(ISG)の機能としては抗ウイルス作用や抗癌作用が良く知られている。ウイルス学分野におけるこれまでの研究では、ISGの抗ウイルス作用に注目した研究が大半であった。一方ISGには500種類を超える遺伝子が知られており、その詳細機能やメカニズムが不明なものも多く、また直接的な抗ウイルス作用以外の機能を持つ遺伝子も報告されている。本研究では最新の遺伝子編集技術(CRISPR/CAS9システム)を用いて作成したゲノムワイドノックアウト細胞ライブラリー、及びISG発現ベクターライブラリーを用いて、ヒトメタニューモウイルス(HMPV)の感染・増殖を増強するISGを同定することを目的としている。
次年度である本年度には、昨年度にHeLa細胞より作出したゲノムワイドノックアウト細胞ライブラリーを用いて同定されたHMPVの感染・増殖に必要な宿主因子に関して詳細な解析を進めた。同定された候補ISGから、特に抗ウイルス作用の発現に重要な役割を果たすISGを選択し、個別ノックアウト細胞を作成した。作成したISGノックアウト細胞を用いてウイルスの感染・増殖に関して検討したところ、一部のISGノックアウト細胞では、HMPVでは感染・増殖が抑制されるが、他のウイルスでは感染・増殖が抑制される、または変化しないことが確認された。これらの結果から、HMPVは一般的に抗ウイルス作用を示すISGをその感染・増殖に利用していることが示唆された。
日本学術振興会, 若手研究, 北海道大学, 20K16270 - ヒトメタニューモウイルス及びパラミクソウイルス増殖に関与する宿主因子の網羅的解析
科学研究費助成事業 若手研究(B)
2017年04月01日 - 2020年03月31日
直 亨則
本研究では最新の遺伝子編集技術(CRISPR/CAS9システム)を用いて作成したゲノムワイドノックアウト細胞ライブラリーを利用して、パラミクソウイルス、及びニューモウイルスのウイルス感染・増殖に必要な宿主因子を同定することを目的としている。昨年度はRSウイルスとHeLa細胞ライブラリーを用いて、RSウイルスの感染・増殖に必要な宿主因子候補250程度を同定したため、今年度はヒトメタニューモウイルス(HMPV)を用いて実験を行った。
HMPVはVeroE6細胞等のサル腎由来細胞には比較的高い感染性を示すが、HeLa細胞等ヒト由来細胞への感染性は限定的である。そのため、HeLa細胞ライブラリーに繰り返しHMPVを感染させるとともに、HeLa細胞ライブラリーをHMPV感染VeroE6細胞と共培養することにより、HeLa細胞ライブラリーのほぼ全ての細胞にウイルスを感染させることに成功した。当初計画では、ウイルス感染後にHeLa細胞ライブラリーの大部分が死滅し、生残細胞(HMPV感染抵抗性細胞)を解析する予定であった。しかし、HMPVは細胞感染時の細胞変性効果が弱く、HMPV感染細胞の大部分が生残しており、HMPV感染に抵抗性を示す細胞を選別することが困難であった。本実験では細胞の生残/死滅以外の指標が必要であり、検討の結果、HMPV感染HeLa細胞はHMPV非感染HeLa細胞と比較して、増殖速度が遅いことが判明した。そこで、HMPV感染HeLa細胞ライブラリーを継代を繰り返して長期間培養することにより、増殖速度の速いHMPV感染抵抗性細胞の割合を高め、HMPVの感染・増殖に必要な宿主因子候補を50程度同定した。
日本学術振興会, 若手研究(B), 国立感染症研究所, 17K16289
